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ABSTRACT 
FUNCTIONAL IDENTIFICATION OF RASGEF1 FAMILY OF EXCHANGE 
FACTORS AS ACTIVATORS OF RAP2, AND AS INTERACTING 
PARTNERS OF CCDC124 
 
 
Elif Yaman 
Ph.D. in Molecular Biology and Genetics 
Supervisor: Dr. Uygar H. Tazebay 
December 2009, 105 Pages 
 
 
 
Coiled coil domain-124 gene is highly conserved among eukaryotes and the human 
counterpart encodes a protein with no domain similarities with any previously 
characterized eukaryotic proteins. In this study, we aimed to identify biological 
functions and interaction partners of human Ccdc-124. A yeast-two-hybrid analysis 
carried in this study has revealed that Ccdc-124 interacts with RasGEF1B which was 
predicted to be a member of Ras guanine exchange factors. The highly conserved 
RasGEF1 family of proteins contain C-terminal CDC25-homology domain (CDC25-
HD) and an N-terminal RasGEF-N domain (Ras Exchange Motif, REM), and is of 
unknown function and specificity. In this thesis, the interaction of Ccdc-124 and 
RasGEF1 family of proteins was also established with co-immunoprecipitation and 
GST pull down assays. On the other hand, by using purified RasGEF1A and 
RasGEF1B proteins, as well as a large number of Ras family of G-proteins, we 
established that RasGEF1A and RasGEF1B function as very specific exchange 
factors for Rap2, a member of the Rap subfamily of Ras-like G-proteins. They do not 
act on Rap1 or other members of the Ras subfamily. On the other hand, Ccdc-124 
protein did not change the stimulatory effect of RasGEF1 family of proteins on any 
of the tested G proteins in vitro. Furthermore, using reciprocal site-directed 
mutagenesis, we analyzed residues that allow RasGEF1 proteins to discriminate 
between Rap1 and Rap2, and we were able to identify Phe39 in the switch I region of 
Rap2 as a specificity residue. Mutation of the corresponding Ser39 in Rap1 changed 
the specificity and allowed the nucleotide exchange of Rap1(S39F) to be stimulated 
by RasGEF1B. This study describes for the first time GEFs that are uniquely specific 
for Rap2 among Rap family of G-proteins. 
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ÖZET 
RAS GUANİN DEĞİŞİM FAKTÖRÜ-1 (RASGEF1) AİLESİ PROTEİNLERİN 
RAP2 AKTİVATÖRLERİ OLARAK TANIMLANMASI VE CCDC-124 İLE 
ETKİLEŞİMİNLERİNİN BELİRLENMESİ 
 
Elif Yaman 
Moleküler Biyoloji ve Genetik Doktorası 
Tez Yöneticisi: Dr. Uygar H. Tazebay 
Aralık 2009, 105 Sayfa 
 
Ccdc-124 geni bütün ökaryot canlılarda korunmuştur. Ccdc-124  proteininde bilinen 
protein  motiflerine gözlemlenmemiştir. Bu tez kapsamında yapılan çalışmalarda, 
maya ikili hibrit analizleri sonucunda, guanin nükleotid değişim faktörü olduğu 
düşünülen RasGEF1B‟nin Ccdc-124 ile etkileştiği bulunmuştur. Fonksiyonu ve 
özelliği bilinmeyen, ancak yüksek oranda korunmuş olan RasGEF1 ailesi 
proteinlerinin, C-ucunda CDC25-Homoloji Bölgesi, N-ucunda ise RasGEF-N, Ras 
Değişim Motifi, bölgesi bulunmaktadır. Ccdc-124 ve RasGEF1 ailesi proteinlerinin 
birbirlerine bağlanması immünopresipitasyon ve GST çöktürme yöntemleri ile de 
doğrulanmıştır. Saflaştırılmış RasGEF1A,  RasGEF1B ve birçok Ras ailesi 
proteinleri kullanılarak yapılan deneylerde, RasGEF1A ve RasGEF1B proteinlerinin 
Ras benzeri G poteinlerinden sadece Rap2‟ye özgün değiştirici faktör olarak 
ekileştiği bulunmuştur. Bu proteinler Rap1 ve diğer Ras ailesi proteinlerine etki 
etmemişlerdir. Diğer yandan, Ccdc-124 proteini, in vitro deneylerde, RasGEF1 
ailesinin hiçbir G proteini stimülasyonunu  da etkilememiştir. Karşılıklı bölge-
yönelimli mutagenez ile RasGEF1 proteinlerinin Rap1 ve Rap2 proteinlerini ayırt 
edici bölgesi analiz edilmiş ve Rap2‟nin switch I bölgesinde yeralan fenilalanin39‟un 
özgüllüğü sağlayan amino asit olduğu bulunmuştur. Rap1 üzerinde bu  bölgeye 
karşılık gelen serin39‟un mutasyonu ise RasGEF1B ile stimülasyonunu 
sağlamaktadır. Bu çalışma sonucunda insan hücrelerinde sadece Rap2‟ye özgün bir 
nükleotid değiştirici faktörün varlığı ilk defa belirlenmiştir. 
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1  INTRODUCTION 
1.1  RAS family of small G proteins 
Small GTP binding proteins together with their effectors and regulators have an 
important role in cell signaling pathways which affects almost all parts of the cell 
system. Most of these small GTP binding proteins belong to a superfamily called 
RAS (Colicelli 2004). Ras genes are found mutated in 20% of all human tumors. The 
highest incidences are found in adenocarcinomas of the pancreas (90%), colon 
(50%), and lung cancers (30%), thyroid tumors (50%), and myeloid leukemia (30%). 
The human Ras superfamily consists of at least 154 members divided into five 
principal families: the Ras, Rho, Rab, Arf, and Ran families (Wennerberg et al. 
2005). This family of proteins has roles in the regulation of cell growth, proliferation, 
differentiation, apoptosis, adhesion and gene expression (Ehrhardt et al. 2002). For 
example, Ran G proteins are responsible for nuclear import and export, the 
regulation of nuclear envelope formation, and the control of spindle formation. 
Members of the Rab and Arf families play important roles in vesicle-associated 
processes, ranging from vesicle formation and transport to exocytosis. The Rho 
family is mainly involved in the regulation of cell shape, the cytoskeleton, and cell 
migration, whereas Ras family members regulate a variety of signaling pathways, 
resulting in transcription and cellular differentiation and proliferation (Bos et al. 
2007).  
1.2 GTPase Activating Proteins (GAPs) 
Small G-Proteins are molecular switches that cycle between an active GTP-bound 
state and an inactive GDP-bound state. Only in the GTP-bound form they interact 
with effector proteins and activate target pathways. For activation, GDP has to be 
released and a new GTP molecule has to be bound. To become inactivated, the 
bound GTP molecule has to be hydrolysed. Although G proteins are also called 
GTPases, the actual GTP hydrolysis reaction is in fact very slow for most of the G 
proteins, and efficient hydrolysis requires the interaction with a GAP, which 
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accelerates the cleavage step by several orders of magnitude. Several structural and 
biophysical studies have unraveled the reaction mechanism. The GTP-bound state is 
stabilized by backbone interactions with their switch I and switch II regions, and the 
γ-phosphate of GTP. Efficient GTP hydrolysis requires the presence of a trans 
element (typically an Arg residue) that interacts with the nucleotide to promote 
hydrolysis (Fig.1.1). The main contribution of different GAPs to catalysis is the 
stabilization of the intrinsically mobile catalytic machinery of the G protein and, in 
most cases, the insertion of a catalytic residue in trans (Weirich et al. 2008). 
 
1.3 Guanine Nucleotide Exchange Factors (GEFs) 
When G proteins are GTP bound, they create a binding site for their downstream 
effector proteins. Activation of RAS proteins is regulated by the catalytic action of 
GEFs. This diverse family includes GEFs acting on p21 Ras proteins (mSos, 
RasGRF, RasGRP) on Rap proteins (RasGRP, Epac, C3G, MR-GEF and RA-GEF), 
and on Ral proteins (RalGDS, Rlf, Rgl) (Quilliam et al. 2002); notably, most GEFs 
can act on more than one GTPase. The GDP/GTP cycle is highly regulated by GEFs 
that induce the release of the bound GDP to be replaced by the more abundant GTP. 
The large number of G proteins requires a multitude of GEFs to ensure signaling 
specificity. GEFs active on the Ras family of proteins share a catalytic domain of 
about 250 amino acids that is homologous with the catalytic domain of CDC25 in 
Saccharomyces cerevisiae and a Ras exchange motif (REM) domain. GEFs are 
usually multidomain proteins, many of which are protein or lipid interaction 
domains, indicating that they serve as localization signals and/or as scaffolds for the 
formation of protein complexes. 
 
1.3.1 General Mechanism of GEF Function 
The affinity of most small G proteins for GDP/GTP is in the lower nanomolar to 
picomolar range. The direct consequence of this high affinity is a slow dissociation 
rate of nucleotides with a half-life on the order of one or more hours. Because 
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exchange of GDP for GTP and, thus, activation of G proteins in biological processes 
occur within minutes or even less, exchange of GDP for GTP requires the activity of 
GEFs. Indeed, GEFs accelerate the exchange reaction by several orders of magnitude 
(Vetter and Wittinghofer 2001). The GEFs are often the targets of biological signals, 
which induce, inhibit, or modulate their catalytic activity. GEFs catalyze the 
dissociation of the nucleotide from the G protein by modifying the nucleotide-
binding site such that the nucleotide affinity is decreased and, thus, the nucleotide is 
released and subsequently replaced. In general the affinity of the G protein for GTP 
and GDP is similar, and the GEF does not favor rebinding of GDP or GTP. Thus the 
resulting increase in GTP-bound over GDP-bound is due to the approximately ten 
times higher cellular concentration of GTP compared to GDP.  
 
In contrast, the affinities of the exchange factor for the nucleotide-bound G protein 
and of the nucleotide for the exchange-factor-bound G protein (the ternary 
complexes) are much lower (Vetter and Wittinghofer 2001). Thus, the interaction of 
a GEF weakens the affinity for the nucleotide, and vice versa, the nucleotide 
weakens the affinity for the GEF. In the course of the exchange reaction the GEF 
displaces the bound nucleotide, and subsequently a new nucleotide displaces the 
GEF. The G-protein-bound nucleotide is sandwiched between two loops called 
switch 1 and switch 2. The switch regions together with the phosphate-binding loop 
(P loop) interact with the phosphates and a coordinating magnesium ion. Both 
phosphates and the magnesium ion are essential for the high-affinity binding of the 
nucleotide to the G protein (Vetter and Wittinghofer 2001). GEF binding induces 
conformational changes in the switch regions and the P loop, while leaving the 
remainder of the structure largely unperturbed. 
 
1.3.2 Regulation of GEF Activity 
Almost all GEFs are multidomain proteins regulated in a highly complex fashion. 
This regulation includes protein-protein or protein-lipid interactions, binding of 
second messengers, and posttranslational modifications. These interactions and 
modifications induce either one or more of three major changes: a translocation to a 
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specific compartment of the cell where the small G protein is located, the release 
from autoinhibition by a flanking domain or region, which covers the binding site for 
the small G protein, or the induction of allosteric changes in the catalytic domain 
(Bos et al. 2007). 
 
 
 
Figure 1.1: The switch mechanism of Nucleotide Exchange. Mechanism relies on the inherently 
low nucleotide-hydrolysis and nucleotide-exchange rates of these proteins. The GTP-bound state 
(panel a) is stabilized by backbone interactions (red circles) in two sequence motifs, known as switch I 
and switch II, and the -phosphate of GTP. Efficient GTP hydrolysis requires the presence of a trans 
element (blue circle; typically an Arg residue) that interacts with the nucleotide to promote hydrolysis 
(red arrow, panel b). The GDP-bound state is also stable, but the interactions between the switch 
motifs and the nucleotide are lost (panel c), in some cases leading to significant changers in the 
structure of the switch regions. Nucleotide exchange requires the contribution of an exchange factor 
(panel d), which stabilizes a relaxed conformation of the GTP-binding (G) domain (red arrows), 
causing GDP to be released and a new GTP molecule to enter the active site (Weirich et al. 2008).  
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1.4 RAP (Ras-Proximal) family of small G proteins 
 Rap proteins are Ras-like small G-proteins, which functions as molecular switches 
by cycling between a GDP-bound inactive and a GTP-bound active state. They 
control a wide variety of cellular process, most notably cell adhesion and cell 
junction formation, which play a crucial role in cell migration and tumor formation. 
On the basis of the sequence homology, the Rap family is divided into two 
subgroups, Rap1 and Rap2, with a total of five members: Rap1A, Rap1B, Rap2A, 
Rap2B, and Rap2C (Paganini et al. 2006). No functional differences have been 
reported between the members of each group. There is about 95% sequence identity 
between Rap1A and Rap1B, and about 90% identity between Rap2A, Rap2B, and 
Rap2C. Effector-binding regions, including switch I, show the highest conservation, 
and C-terminal regions the lowest. Similarly, Rap1 proteins are closely related (about 
70% identical) to Rap2 subfamily members. Although identical or overlapping 
functions have been described for Rap1 and Rap2 proteins (Christian et al. 2003; 
McLeod et al. 2002; McLeod et al. 2004), a number of studies showing functional 
distinctions and different effector–protein interactions have been reported for Rap1 
and Rap2 proteins (Fu et al. 2007; Huang et al. 2004; Imamura et al. 2003; Zhu et al. 
2005). 
1.4.1  RAP1 
Rap-GEF/Rap signaling regulates the formation of adherens junctions. RAP1 was 
first identified as a gene that could reverse the loss of adhesion observed in NIH3T3 
cells transformed by K-Ras (Kitayama et al. 1989). Subsequently, activation of Rap 
GTPases has been shown to increase cell adhesion and spreading and also to play a 
role in migration (Arthur et al. 2004; Enserink et al. 2004; Price and Bos 2004; Price 
et al. 2004). Although the mechanism of Rap activity is not completely understood, 
there is convincing evidence that activated Rap promotes adhesion through integrin 
activation (Bos et al. 2003; McLeod et al. 2004; Reedquist et al. 2000). RAP 
proteins are activated by mitogenic stimuli and function as regulators of integrin 
mediated cell adhesion and cell spreading. In cultured cells, RAP proteins do not 
show transforming activity. Rather, overexpression of RAP1A inhibits RAS 
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mediated transformation. However, RAP1A has been reported to bind and activate 
BRAF, suggesting that it has the capacity to promote mitogenesis and perhaps 
transformation in some cases. Two observations suggest contributions of RAP 
proteins in tumorigenesis, but with possible tissue type specificity. Activation of a 
RAP directed GEF or inactivation of a RAP directed GAP promotes hematopoietic 
tumor formation. Conversely the loss of an activator of RAP1 proteins has been 
found in a mouse osteosarcoma and in several nonhematopoietic human cancer cell 
lines (Colicelli 2004).  
Recent studies have suggested that Rap1 may actually regulate adherens junctions. 
Cell-cell junctions are formed evenly around the lateral circumference of cells by 
homophilic interactions between the extracellular domains of E-cadherin, linked by 
their intracellular tail to catenins and to the actin cytoskeleton (Jamora and Fuchs 
2002). Two recent studies in mammals have shed new lights on the connection 
between Rap1 and adherens junctions. In the first study, a Rap1 GTPase activator, 
DOCK4, was identified as a tumor suppressor (Yajnik et al. 2003). DOCK4 
specifically activates Rap1 and regulates the formation of adherens junctions. In the 
second study, the authors demonstrated that ligation of the extracellular domain of E-
cadherin enhances Rap1 activity, and that active Rap1 regulates the subsequent 
accumulation of at newly formed cellcell contact sites (Hogan et al. 2004). Data from 
the second study suggests that formation of adherens junctions is a two-step process. 
When cells first contact one another, small clusters of E-cadherin ligate through the 
homophilic interaction, which may, in turn, induce the activation of Rap1; activation 
of Rap1 may then activate inside-to-outside signaling through stimulating actin 
polymerization, which mediates the further recruitment of E-cadherin from the 
cytoplasmic or plasma membrane pool and facilitates the formation of mature E-
cadherin-based adherens junctions. In Drosophila, it is reported that, Rap1 regulates 
the even distribution of adherens junctions of epithelial cells in wing imaginal disc 
(Knox and Brown 2002); Rap1 null cells have uneven adherens junctions and are 
dispersed into neighboring cells. 
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1.4.2 RAP2 
Knowledge about Rap2 is limited. Rap2 is a member of the Ras family of small 
GTPases whose effector domain is almost identical to that of Ras, and can therefore 
bind most Ras effectors. Rap2 inhibits many Ras pathways including Ras-induced 
Raf activation at the plasma membrane (Ohba et al. 2000). Rap2 also binds to the Ral 
GEFs, Ral GDS, RGL and RLF (Nancy et al. 1999). These proteins are also Ras 
effectors and induce nucleotide exchange leading to the formation of active RalA. 
Rap2 is reported to localize
 
mainly in the endoplasmic reticulum (ER), whereas Rap1 
localizes
 
at the Golgi apparatus (Beranger et al. 1991; Beranger et al. 1991). Unlike 
Rap1, Rap2 cannot
 
reverse Ras-induced transformation of NIH 3T3 cells (Jimenez et 
al. 1991), and
 
no biological phenotype has been linked to Rap2 in the literature.
 
The 
regulation of Rap2 also remains unknown. Rap1GAP stimulates
 
Rap2 GTPase 
activity in vitro, albeit significantly more weakly
 
than Rap1 (Janoueix-Lerosey et al. 
1992). PDZ-GEF1,
 
also activates Rap2 and that GTP-bound Rap2 makes up more 
than
 
50% of the Rap2 in A14 and COS1 cells (Ohba et al. 2000).  
In Xenopus embryos, Rap2 was shown to regulate activin/nodal signaling by 
modulating receptor trafficking (Choi et al. 2008). In the absence of ligand, Rap2 
directs activin/nodal receptors into a Rab11-dependent recycling compartment, 
thereby avoiding degradation and maintaining cell-surface levels of receptors. Upon 
ligand addition, Rap2 no longer directs the receptors for recycling, but rather 
competes with Smad7 and delays receptor degradation, thus enhancing signaling 
(Colicelli 2004). Recently, specific Rap2-binding proteins such as RPIP8, TNIK and 
MAP4K4 were reported as candidate effectors; however, their cellular functions as 
Rap2 effectors are not fully established (Kardassis et al. 2009). 
Further research in another eukaryote model, C. elegans, have revealed that there are 
three Rap-like genes. rap-1 and rap-2 are very similar to vertebrate Rap-1b and Rap-
2a. rap-3 shows less similarity to vertebrate Rap genes but is most similar to Rap-1b. 
Rap function in C. elegans involves the function and morphogenesis of hypodermal 
cells but not their generation or specification (Pellis-van Berkel et al. 2005). rap-1 
mutants display defects in hypodermal morphogenesis and function, including 
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formation of adherens junctions, secretion of cuticle and basement membrane, and 
hypodermal cell integrity and viability. While rap-2 mutations on their own are wild-
type, rap-2 mutations enhance the effects of rap-1, suggesting that rap-1 and rap-2 
act redundantly and can partially compensate for each other's loss (Pellis-van Berkel 
et al. 2005).  
1.5 RAP Guanine Exchange Factors  
Particularly, GEFs enhance the formation of the GTP-bound active conformation in 
response to upstream signals mediated by various cell surface receptors. To date, a 
number of GEFs for Rap proteins have been identified like, C3G, Epac (or cyclic 
AMP [cAMP]-GEF), CalDAG-GEFI, PDZ-GEF1,
 
and GFR (Repac). These multi-
domain proteins are highly regulated and responsible for the temporal and spatial 
activation of Rap. The Rap-GEFs Epac1 and Epac2 are directly regulated by cAMP 
and particular Epac2 modulates insulin secretion from pancreatic cells (Rehmann 
2006). C3G binds to the adaptor protein Crk, being involved in tyrosine kinase-
dependent activation of Rap1 (Gotoh et al. 1995). Epac/CAMPGEF is activated 
through direct association with cAMP, thereby stimulating Rap-dependent signaling 
(de Rooij et al. 1998; Kawasaki et al. 1998). Another Rap GEF, CalDAGGEF1, 
which contains calcium and diacylglycerol binding motifs, has a role in Rap 
activation in response to these second messengers (Kawasaki et al. 1998). Another 
Rap GEF is RAGEF-1 (also termed PDZ-GEF1, nRapGEP, or CNrasGEF), which 
exhibits GEF activity toward Rap1 and Rap2 (Liao et al. 1999; Liao et al. 2001). 
RA-GEF-1 contains putative cNMP-binding, REM, PDZ, and RA domains as well as 
the GEF catalytic domain. RA-GEF-2, whose structural features are intimately 
related to RA-GEF-1, exhibits GEF activity toward Rap1 and Rap2. GFR (Repac), 
which lacks the cAMP dependent regulatory sequences, is a constitutive activator of 
both Rap1 and Rap2 (Gao et al. 2001). 
 
1.6 RasGEF1 Family  
Proteins that act as Guanine exchange factors of Ras can be classified into at least 
two families, on the basis of sequence similarities, the CDC24 family and the CDC25 
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family. The size of the proteins of the CDC25 family range from 309 residues 
(LTE1) to 1596 residues (Sos). The sequence similarity shared by all these proteins 
is limited to a region of about 250 amino acids generally located in their C-terminal 
section (currently the only exceptions are sos and ralGDS where this domain makes 
up the central part of the protein). This domain has been shown, in CDC25 an 
SCD25, to be essential for the activity of these proteins. 
The crystal structure of the GEF region of human Sos1 complexes with Ras has been 
solved. The structure consists of two distinct alpha helical structural domains: the N-
terminal domain which seems to have a purely structural role and the C-terminal 
domain which is sufficient for catalytic activity and contains all residues that interact 
with Ras. A main feature of the catalytic domain is the protrusion of a helical hairpin 
important for the nucleotide-exchange mechanism. The N-terminal domain is likely 
to be important for the stability and correct placement of the hairpin structure. The 
signature pattern for this entry spans the helical hairpin. 
The rasgef genes encode a subgroup of highly conserved Ras guanine nucleotide 
exchange factors. While EST projects revealed the presence of rasgef genes in 
organisms that range from nematodes to humans, their functions remain to be 
elucidated. In zebrafish two rasgef genes, rasgef and rasgef1b, have been identified 
and high throughput analysis revealed tissue specific embryonic expression for 
rasgef1b. The combined data generated from EST projects and genome-scanning 
gene-prediction programs suggest that vertebrates have three distinct rasgef genes 
and that only two of these genes are present in zebrafish. Phylogenetic analysis of the 
predicted RasGEF proteins show that the fish and mammalian proteins have slightly 
diverged during evolution. Furthermore, the cDNA of this zebrafish gene has a 
slightly higher homology to mammalian rasgef1b (73%) than to rasgef1c (66%) and 
rasgef1a (64%).  In common, the RasGEF proteins possess two domains, a highly 
conserved carboxy-terminal RasGEF domain and a slightly less conserved amino-
terminal RasGEFN domain (Figxx) with a yet unknown function. At the level of the 
protein sequence, vertebrate RasGEF1B proteins display 80–95% identity in the 
RasGEFN domain and 91–98% identity in the RasGEF domain. RasGEF domains 
  
10 
normally activate small GTPases of the Ras/Rho family by catalyzing the exchange 
of the inactive GDP-bound form to the activated GTP-bound form (Quilliam et al., 
2002). It is shown that three rasgef1b-transcripts are generated from two 
transcriptional start sites and by alternative splicing. Detailed expression analyses 
show that rasgef1b is expressed in a subset of adaxial cells, in the anterior part of 
somites, in the rostral part of the mid-hindbrain boundary and in the rhombomere 
boundaries. In the larva, rasgef1b is further expressed in the pallium and the inner 
nuclear layer of the retina. It is also found that rasgef1b is expressed maternally and 
that the ubiquitous distribution of maternal transcripts disappears shortly after mid-
blastula transition. At early epiboly stages, rasgef1b expression is restricted to the 
margin with low levels of expression on the ventral and high levels of expression on 
the dorsal side. It is also showed that early zygotic expression is regulated by Nodal 
and FGF signals and that these signals have different activities in regulating the level 
and distribution of early zygotic rasgef1b mRNA expression (Epting et al. 2007). 
Whether or not RasGEF1B proteins have a similar function remains to be 
investigated, particularly because their GEF domains display characteristic 
differences when compared to the GEF domains of the related Ras activating 
proteins CDC25 and SOS (Jones et al. 1991). Till now, the only evidence for a 
biological function of RasGEF1B proteins comes from studies in invertebrates. 
Drosophila and Caenorhabditis elegans both contain a single rasgef1b-related gene, 
named rasgef, which shows 35% and 36–37% identity to the genes encoding the 
vertebrate RasGEF1B proteins, respectively (Kiger et al. 2003). In large scale RNAi 
experiments, knock down of Drosophila RasGEF in Schneider-cells was found to 
result in a slight change in cell morphology. However, no defects were found when 
Drosophila or C. elegans rasgef were knocked down in the entire organism (Rual et 
al. 2004).  
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Figure 1.2: The RasGEF proteins possess two domains, a highly conserved carboxy-terminal 
RasGEF domain and a slightly less conserved amino-terminal RasGEFN domain. RasGEFN domain 
spans 33
th
 to 161
st
 residues, RasGEF domain through 201
th
-454
th
 residues. 
 
1.7 Objectives and Rationale 
Previously, our laboratory has established the expression of a novel gene of unknown 
function, Ccdc-124, in a number of cell lines tested. Intrigued by a very high 
conservation of this gene among eukaryotes, we decided to establish the biological 
function of Ccdc-124. For this, we have first used the well known yeast-two-hybrid 
technique, and screened a liver cDNA library in order to identify interaction partners 
of Ccdc-124. These analysis have revaled RasGEF1B as a potential interaction 
partner. We have then validated these results by a number of in vitro and in vivo 
protein-protein interaction assays. Even though proteins belonging to RasGEF1 
family were predicted to act as guanine exchange factors for Ras G-proteins, their 
precise biological functions were ambigious, and G-proteins stimulated by RasGEF1 
family members were unknown. Therefore, we decided to test the guanine exchange 
factor activities of proteins belonging to this family, and we settled to identify Ras 
family of G-proteins stimulated by these GEFs in in vitro guanine nucleotide 
exchange assays. We have identified Rap2, a member of Ras family of G-proteins as 
substrate of RasGEF1A and RasGEF1B, and we then aimed to study residues having 
discriminatory roles in the interactions between RasGEF1s and Ras Family of G-
proteins. In parallel to these studies, we have also studied the effect of Ccdc-124 in 
RasGEF1 stimulated guanine nucleotide exchange activities in vitro. 
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2 MATERIAL & METHODS 
2.1 Yeast Two Hybrid 
Bait cloning and Y2H screening were performed by Hybrigenics, S.A., Paris, France 
(http://www.hybrigenics.com).  
Human CCDC124 (aa1-aa223) cDNA was PCR-amplified and cloned in a LexA, C-
terminal fusion vector optimized by Hybrigenics. The bait construct was checked by 
sequencing the entire insert, and was subsequently transformed in the L40 GAL4 
yeast strain (Fromont-Racine et al. 1997).A Human Liver random-primed cDNA 
library, transformed into the Y187 yeast strain and containing ten million 
independent fragments, was used for mating. High mating efficiency was obtained by 
using specific mating method (Legrain et al., 1998, 2000, 2002). The screen was first
 
performed on a small scale to adapt the selective pressure to
 
the intrinsic property of 
the bait. No autoactivation of the bait was observed. Then, the full-scale screen
 
was 
performed in conditions ensuring a minimum of 50 million interactions
 
tested, in 
order to cover five times the primary complexity of the yeast-transformed
 
cDNA 
library (Rain et al. 2001). 98 millions of interactions were actually tested with 
Human CCDC124. After selection on medium lacking
 
leucine, tryptophane, and 
histidine, 16 positive clones were picked, and the corresponding prey
 
fragments were 
amplified by PCR and sequenced at their 5' and
 
3' junctions.  
Sequences were then filtered and contiged (Formstecher et al. 2005) and compared to 
the latest release of the GenBank database using
 
BLASTN (Altschul et al. 1997). A 
Predicted Biological Score (PBS) was attributed to assess the reliability of each 
interaction, as described previously (Formstecher et al. 2005). Briefly, the PBS relies 
on two different levels of analysis: firstly a local score takes into account the 
redundancy and independency of prey fragments, as well as the distributions of 
reading frames and stop
 
codons in overlapping fragments. Secondly, a global score 
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takes into account the interactions found in all the screens performed at Hybrigenics 
using the same library. In addition, potential false-positives are flagged by a specific 
“E” PBS score. This is done by discriminating prey proteins containing “highly 
connected” domains, previously found several times in screens performed on 
libraries derived from the same organism. The PBS scores
 
have been shown to 
positively correlate with the biological
 
significance of interactions (Rain et al. 2001; 
Wojcik et al. 2002). 
2.2 Northern Blotting 
Northern blotting was performed on FirstChoice Northern Human Blot1 membrane 
(each lane containing 2 µg poly (A) RNA) (Ambion). DNA templates for probe 
preparation were formed via restriction enzyme digestion from PCR product cloned 
plasmids for Ccdc-124 and RasGEF1B or directly from PCR products for Gapdh and 
β-actin. PCR products for Gapdh and β-actin formed via primers which were kindly 
provided by Ayşe Elif Erson and Mehmet Öztürk‟s group, respectively. Then, DNA 
templates were labeled by north2south biotin random prime labeling kit (Pierce). 
Probes were synthesized as described in manufacturer‟s protocol. Probes and their 
sizes are presented in Table 2.6. 
Gene Starting material Restriction Enzyme Probe Size 
Ccdc-124 p3XFlagCcdc-124 Apa I and Xba I 381 bp 
RasGEF1B p3XFlagRasGEF1B Bgl II and BamHI 284 bp 
Gapdh Gapdh PCR product - 408 bp 
β-actin β-actin PCR product - 539 bp 
Table 2.6:  Northern blotting probes. Starting DNA material, used restriction enzymes for probe 
synthesis and synthesized probe sizes are indicated.  
 
In order to hybridize the nucleic acids and perform the detection by synthesized 
probes, north2south chemiluminescent hybridization and detection kit (Pierce) was 
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utilized. Kit‟s protocol was exactly followed and resulting blots were exposed to film 
for approximately 1 min. 
2.3 Cell Culture 
In this study, Huh-7 (Human hepatocellular carcinoma), HeLA (Human Cervical 
carcinoma) and MCF-7 (Caucasian female breast adenocarcinoma) cell lines were 
used for immunoprecipitation, immunostaining and western analysis. 
Cell lines were grown in high glucose Dulbecco‟s modified Eagle‟s medium (Gibco) 
with the addition of 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 
1% L-glutamine (Biochrom) at 37˚C in a 5% CO2 incubator.  
2.3.1 Transfection 
Transfection was performed via using FuGene-6 reagent (Roche). Optimized 
transfection reagent (µl) /plasmid DNA (µg) was 3:1. Firstly, transfection reagent 
was diluted in serum and antibiotics free medium. After 10 minutes of incubation, 
plasmid DNA was added and FuGene-plasmid DNA mixture was incubated for 30 
minutes. During this time interval, medium of the cells was changed. Finally, 
FuGene-DNA complex was transfected to cells in a drop-wise manner.  
2.4 Western blot analysis 
Proteins from cell lines were isolated for western blotting analysis. Cell pellets were 
lysed in 50 µl lysis buffer consisting of 50mM Tris Base, 250mM NaCl, 1X 
proteinase inhibitor cocktail and 0.1% NP40. Protein concentrations were determined 
via using Bradford assay. Twenty micrograms of whole cell extracts were denatured 
in gel loading buffer [50 mM Tris-HCl pH 6.8, 1% SDS, 0.02% bromophenol blue, 
10% Glycerol and 5% 2-mercaptoethanol] at 95°C for 5 min, resolved by SDS-
PAGE using a 10% gel, and electrotransferred onto PVDF membranes (Millipore). 
The membranes were blocked in Blotto (Tris-buffered saline containing 0.5% Tween 
20 and 5% nonfat milk powder) for 1 hour at room temperature. The membranes 
were incubated with first antibody (Table 2.7) for 1 hour, washed 3 times with Blotto 
and incubated with secondary antibody (see below) for 1 hour, immunocomplexes 
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were then detected via Super Signal West Dura (Pierce), and exposed to X-Ray films 
(AGFA) for 1 minute. The films were then developed using a hyper-processor 
developer (Amersham).  
Primary antibody Description Concentration in blotto 
Anti-Ccdc-124 Rabbit, polyclonal 2 µg/ml 
Anti-Flag (Sigma) Mouse, monoclonal 1 µg/ml 
Anti-Calnexin  Rabbit, polyclonal 0.1 µg/ml 
Anti-His-Probe(Santa 
Cruz) 
Rabbit, polyclonal 1 µg/ml 
Table 2.7: First antibodies used in Western Blot experiments. 
 
2.5 Immunostaining 
Cells that cultured on cover slips in 6-weel plates were washed 3 times with cold 
1XPBS (137 mM NaCl, 2,7mM KCl, 1,4 mM KH2PO4, 4,3 mM Na2HPO4) then 
fixed with 4% Para-formaldehyde at room temperature for 15 min. After fixation 
cells were permeabilized with 1:1000 Triton X100 in 1XPBS for 6 min at room 
temperature. Cells then blocked with 5% BSA in1XPBS for 1 hour at room 
temperature, then incubated with first antibody which is diluted in blocking solution 
for 1 hour. After first antibody incubation cells were washed 3 times with 1XPBS 
and incubated with TRITC or FITC conjugated secondary antibody diluted in 
blocking solution for 1 hour at room temperature. Then cells were washed for 3 times 
with 1XPBS and counter stained with DAPI for 30 sec, washed with dH2O and 
mounted with glycerol. 
2.6 GST-Pull Down Assay 
100µl 50% slurry (~50µl packed) GSH beads were washed 3 times with wash buffer 
(50mM Tris HCl pH 7.5, 100mM NaCl, 3mM β-Mercaptoethanol). First two vials 
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incubated (immobilized) with 200µg purified GST-RasGEF1 protein, second vial 
incubated (immobilized) with 200µg GST protein, fourth vial just incubated with 
wash buffer and rotated at 4
◦
C for 1 hour. After immobilization, beads were washed 
3 times. First and third vials incubated with eash buffer only, second and fourth vials 
incubated with 500µg Ccdc-124 protein and incubated at 4◦C for 1 hour by rotating. 
Then beads were washed 9-10 times with wash buffer, and samples were eluted with 
40µl 4x SDS loading buffer, boiled for 5 min and loaded on an SDS gel. For the 
control of of protein sizes 10mg/ml from each protein were loaded to the same gel. 
The gel then stained with coomasie for 15 min and destained with water. 
2.7 Polarization Assay 
2.7.1  IAEDANS Labelling 
Cystein mutants of purified Ccdc-124 proteins were washed with 50mM Tris HCl 
(pH 7.5), 100mM NaCl, 5mM Ascorbic Acid in eppendorf concentrators and 0.5mg 
of them incubated with 10 times molar concentration of IAEDANS overnight at 4
◦
C.  
2.7.2 Fluorescence Polarization 
Monitoring protein-protein interactions by using fluorescence polarization. After 
excitation with polarized light, the photons emitted by fluorescent probes are also 
polarized; however, rotational diffusion of a fluorophore over its excitedstate lifetime 
causes depolarization of the emitted photons. Fluorescence polarization measures the 
average angular displacement of a fluorophore over its excited-state lifetime, which 
is affected by the molecule‟s rate of rotational diffusion. Because the rate of 
rotational diffusion of a molecule is inversely related to its size, polarization provides 
a sensitive measure of changes in molecular volume that occur when the fluorescent 
protein is bound by a nonfluorescent protein (Harrington et al. 2003). Fluorescence 
polarization was used to monitor the association of IAEDANS-labeled Ccdd-124 
with nonfluorescent RasGEF1B. Measurements were performed at 25°C in 20 mM 
Tris HCl (pH 7.5), 50 mM NaCl, 5 mM MgCl2, 3 mM β-mercaptoethanol in quartz 
cuvettes. Fluorescence data were recorded with a Fluoromax-2 spectrophotometer, 
with excitation and emission wavelengths of m-nucleotides at 336 nm and 450 nm, 
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respectively. Firstly the polarizations of 2.5µM IAEDANS labeled Ccdc-124 
proteins alone were measured and then 20nM RasGEF1B protein was added each 
time with time laps.   
2.8 Protein Imunoprecipitation Assay 
70-90% confluent (100mm dish) cells were rinsed twice with PBS (10mM 
phosphate, 2.7mM potassium chloride, 137mM sodium chloride, pH 7.4) and 1 ml of 
lysis buffer (50mM Tris HCl, pH 7.4, with 150mM NaCl,1mM EDTA, and 1% 
TRITON X-100) was added and incubated for 15−30 minutes on a shaker at 4°C. 
Then cells were scraped, collected and centrifuged at 12,000Xg for 10 min. 
Supernatant transferred onto 40µl 50% slurry ANTI-FLAG M2 affinity gel (Sigma) 
and incubated overnight on shaker at 4°C. Subsequently the resin was washed three 
times with 1ml TBS. 20 µl of 2Xsample buffer (125mM Tris HCl, pH 6.8, 4% SDS, 
20% (v/v) glycerol, 0.004% bromphenol blue) was added to each sample. After 
denaturation by boiling for 3 min, samples were loaded on SDS-PAGE and 
immunoblotted with specific antibody against the Ccdc-124 protein and anti-Flag 
antibody against the fusion RasGEF1B protein. 
 
2.9 Plasmid Constructs 
cDNAs corresponding to the RasGEF1A and RasGEF1B genes were cloned into the 
pQE80L system by Hani Alotaibi and Pelin Telkoparan. Then these cDNAs were 
transferred into pGEX-4T-1 expression vector: cDNAs corresponding to RasGEF1A 
and RasGEF1B were amplified by PCR (Table 2.1) with the primers (Table 2.2) 
suitable for pGEX cloning, and then fragments were purified from agarose gel. 
RasGEF1A and RasGEF1B were digested at 37
◦
C overnight with their suitable 
enzymes. pGEX-TEVn was also digested first with EcoRI at 37
◦
C overnight and then 
EcoRI was inactivated at 65
◦
C for 20 min. and divided into two vials. One was 
digested with BamHI and the other half was digested with NcoI at 37
◦
C for 2 hours. 
Then digested samples were purified from agarose gel and ligated with RasGEF1A 
and RasGEF1B fragments (Table 2.3). After ligation they were transformed into 
Top10 competent cells and spread on 50µg/ml Amp included LB agar plates. After 
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incubating the plates overnight at 37
◦
C colonies were picked and a colony PCR was 
made in order to select the positive colonies. Then the plasmids from positive 
colonies were isolated and sequenced. 
DiRas2, M-Ras, R-Ras, RalB, TC21, RERG and Rheb were cloned into pGex4T1–
TEV and expressed in E. coli BL21 DE3 cells. C-terminally truncated forms of H-
Ras, Rap1A, Rap1B and Rap2A were cloned into ptac vectors and expressed in 
CK600K cells by Raphael Gasper.  
 
 
Tablo 2.1: PCR Reaction of RasGEF1A and RasGEF1B by using pQE80L-RasGEF1A and 
pQE80L-RasGEF1B as template. Conditions: 94
◦
C 4min, (94
◦
C 30sec, 53
◦
C 60sec, 72
◦
C  60sec)x30, 
72
◦
C  4 min. 
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RASGEF 1A Forward (BamHI) 
5‟-CGT AGG ATC CAT GCC CCA GAC GTC CGT TGT C-3‟ 
RASGEF 1A Reverse (EcoRI) 
5‟-GGT AGA ATT C TC AGG CTC TGT TCA GAA GGG TG-3‟ 
RASGEF 1B Forward (Nco I) 
5‟-CTG CCC ATG GGC ATG CCT CAG ACT CCT CCC TTT TC-3‟ 
RASGEF 1B Reverse (BamHI) 
5‟-CCT AGG ATC CAT GCC ACA GAC GCT GAG TGC C-3‟ 
Table 2.2: RasGEF1A and RasGEF1B primers for cloning into pGEX system. 
 
 
 
Table 2.3: Digestion and ligation reactions of RasGEF1A, RasGEF1B and pGEX-Tevn  
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2.10 Protein Purification 
2.10.1  Small Scale Expressions of pQe80L-RasGEF1 and pQe81L-Ccdc-124 
BL21 codon+ RIL competent cells transformed with pQE80L-RasGEF1 and 
pQE81L-Ccdc-124 for test expression.  
200 µl competent cell + 1 µl plasmid DNA on ice for 30 min, heat shock at 42◦C  for 
1 min then add 500 µl LB and shake for 1 hour at 37◦C. After 1 hour of shaking, 100 
µl was spread over an agarose plate which has 50µg/ml ampisilin (Amp) + 25µg/ml 
chloramphenicol (Cam) in it and incubated overnight at 37
◦
C. The next day half of 
the colonies grew on the plates scaped into 400 ml LB flasks which have 50µg/ml 
Amp and 25µg/ml Cam. Flasks were shaked at 23◦C till they reached the A600 nm of 
0.4. When they reached the A600 nm of 0.4, 1 ml of “uninduced” control was taken 
from each of them and the rest is induced with 100 µM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and divided into two flasks, one was grown at 16
 ◦
C 
the other was grown at 23
 ◦
C. Next day 1 ml of induced control was taken from each 
flask then they divided into three 50 ml falcons so that there were 3 samples for 3 
different lysis buffers, lysis buffer1, 2 and 3 (see below). 
Falcons were centrifuged and pellets were lysed with different lysis buffers. After 
dissolving pellets with lysis buffers, 100 µM phenylmethanesulphonylfluoride or 
phenylmethylsulphonyl fluoride (PMSF) was added and each was sonicated with 
microtipped sonicator at the maximum level with 50% amplitude, 50 seconds for 2 
times. 10 µl control samples were taken from them, then 1 ml from each sample was 
centrifuged at 4
 ◦
C and 14000 rpm for 30 min and 10 µl sample was taken as a Raw 
Extract (RE) control, the rest is incubated with 50 µl 50% Ni-beads for 30 min at 4 
◦
C. 10 µl Flow Though (FT) control was also taken before the beads were washed. 
After 5 times washing step with their corresponding washing buffers, beads were 
eluted with 4x sample buffer. All the samples heated up to 95
 ◦
C for 5 min then 
loaded in 15% SDS gels and ran at 70mA/gel for 30 min and gels were stained with 
coomassie for 15 min then destained with water. 
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2.10.2  Large Scale Expression of Ccdc-124 
5L culture of pQE81L Ccdc-124 in BL21 codon + RIL E.coli cells was grown at 
23
◦
C till the A600 nm reached to 0.5. 1ml of “uninduced” control sample was taken 
and the rest was induced with 100mM IPTG overnight and pelletted by centrifuging 
at 4400 rpm at 16
 ◦
C  for 15 min. Pellets were resuspended with lysis buffer 1 (see 
below) and 100mM PMSF was added. Then pellets were lysed by using midi-tipped 
sonicator at the maximum level with 50% amplitude, 50 seconds for 2 times on ice. 
Cell lysate supernatants were applied to Ni-NTA-agarose column, pre-equilibrated 
with lysis buffer 1 at 4
◦
C and washed first with wash buffer 1 then with high salt 
buffer. Then eluted with a linear gradient up to 1M imidazole in elution buffer (pH 
8.0) and 4ml fractions. Fractions were loaded on a 15% SDS gel, and then all 
fractions pooled together and concentrated (with Millipore Amicon Ultra Centrifugal 
Filter 10 NMWL). Concentrated samples were loaded on Superdex S75 26 ⁄ 60 
columns (Amersham Biosciences) (gel filtration). Fractions after gel filtration were 
loaded to a 15% SDS gel and the proper fractions were pooled together and 
concentrated. 
Lysis Buffers: 
Lysis Buffer 1: 50 mM Tris pH 7.5, 300 mM NaCl, 3 mM β-Mercaptoethanol, 0.5% 
NP40, 0.5% Triton X100 
Lysis Buffer 2:  50 mM Tris pH 8, 300 mM NaCl, 3 mM β-Mercaptoethanol, 0.5% 
NP40, 0.5% Triton X100 
Lysis Buffer 3: 50 mM Tris pH 7.5, 300 mM NaCl, 3 mM β-Mercaptoethanol 
Lysis Buffer with Detergent: 50 mM Tris pH 7.5, 300 mM NaCl, 3 mM β-
Mercaptoethanol, 0.5% NP40, 0.5% Triton X100 
Lysis Buffer without Detergent: 50 mM Tris pH 7.5, 300 mM NaCl, 3 mM β-
Mercaptoethanol. 
Wash Buffers:   
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Wash Buffer 1: 50mM Tris HCl pH 7.5, 100mM NaCl, 3mM β-Mercaptoethanol 
Wash Buffer 2: 50mM Tris HCl pH 8, 100mM NaCl, 3mM β-Mercaptoethanol 
High Salt Buffer: 50mM Tris HCl pH 7.5, 300mM NaCl, 3mM β-Mercaptoethanol, 
1mM ATP 
Column Elution Buffer 1 pH 8.0: 50mM Tris HCl pH 7.5, 100mM NaCl, 3mM β-
Mercaptoethanol, 20mM Glutathion  
Column Elution Buffer 2 pH 8.0: 50mM Tris HCl pH 7.5, 100mM NaCl, 3mM β-
Mercaptoethanol, 1M immidazole 
2.10.3  Protein expression and purification of wild type G proteins  
DiRas2, M-Ras, R-Ras, TC21, RalB, RERG, Rheb, ptac–H-Ras, ptac–Rap1A, ptac–
Rap1B and ptac– Rap2A were expressed at 25◦C after induction with 100 Mm IPTG 
at a A600 nm of 0.6. Cell lysate supernatants of GST-fused RasGEF1A and 
RasGEF1B were applied to a glutathione (GSH) column (Amersham Biosciences, 
Freiburg, Germany) pre equilibrated with buffer A [50 mm Tris (pH 7.5), 100 mM 
NaCl, 3 mM β-mercaptoethanol] at 4 ◦C and eluted with buffer A containing 20 mM 
GSH, and GST fusion proteins were purified by gel filtration on Superdex S75 16 ⁄ 
60 columns (Amersham Biosciences). Cell lysate supernatants of the GST-fused G-
proteins were applied to GSH Sepharose 4B (GE Healthcare, Chalfont St Giles) pre-
equilibrated with buffer B [25 Mm Tris (pH 7.5), 500 Mm NaCl, 5 
Mmdithioerythritol] at 4 
◦
C, and either eluted with 20 Mm GSH and subsequently 
digested by Tobacco Etch Virus (TEV) protease (1mg/ml) in batches, or cleaved by 
thrombin (300U) on the column. Cleaved proteins were further purified by gel 
filtration and another GSH column to separate G-proteins from GST; ptac-cloned 
proteins were purified by Q-Sepharose and subsequent gel filtration.  
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2.10.4  Site Directed Mutagenesis 
PGEX-4T-3–Rap1B, pGEX-4T-3–Rap2A and pQE81L-Ccdc-124 mutants were 
generated using a Stratagene QuickChange site-directed mutagenesis kit by using 
primers below (Table 2.4 and Table 2.5). For templates smaller than 5kb, 50ng DNA; 
longer than 5kb, 100ng DNA was used. After mutagenesis PCR reaction, samples 
were subjected to Dpn I digestion and transformed into Top10 competent cells. The 
plasmids were isolated and their sequences were verified by sequencing.  
Ser12 to Cys   (TCG→TGC)           
5‟GGTGAGAACACCAAGTGCGCAGCGGCCCGGG 3´ 
Ser92 to Cys   (TCC→TGC) 
5‟CCGCGGGTGGCCACGTGCAGCAAGGTCACCC3´ 
Ser155 to Cys   (AGC→TGC) 
5´GCCATTGCAGTGCTCTGCGTGGCGGAGGAGGCG3´ 
Table 2.4: Ccdc-124 Mutagenesis Oligos. 
 
Rap2A T27I   ACC →ATC    
5´GCAGTTCGTGACCGGCATCTTCATCGAGAAATACG-3´ 
Rap2A F39S  TTC→TCC     
5´CCCCACCATCGAGGACTCCTACCGCAAGGAGATCG-3´ 
Rap2A S66A  TCC→GCC    
5´CCGAGCAGTTCGCGGCCATGCGGGACCTGTAC-3´ 
Rap1B S39F   TCT→TTT     
5´CCTACGATAGAAGATTTTTATAGAAAGCAAGTTG-3´ 
Table 2.5: Mutagenesis Oligos of Rap2A and Rap1B. 
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2.10.5 Mant-GppNHp Exchange Reaction 
Two milligrams from each protein was loaded with N-methylanthranil acid-labeled 
guanine nucleotide (mant-GNP) by incubating with 400µM mGppNHp and 1 U.mg-1 
alkaline phosphatase (Roche Diagnostics, Indianapolis, IN, USA) in an exchange 
buffer [200mM (NH4)2SO4, 1mM ZnCl2] for 16 h at 4
◦
C overnight at dark. 
Exchange of nucleotides was monitored by HPLC. After exchange, proteins were 
separated from free nucleosides and alkaline phosphatase by gel filtration (S75 10 ⁄ 
30). Purified proteins were concentrated, flash-frozen in liquid nitrogen, and stored at 
80 
◦
C. 
2.11 Nucleotide exchange reaction (GEF Assay) 
The dissociation of a protein-bound nucleotide was determined in real time by 
fluorescence spectroscopy using a fluorescent N-methylanthraniloyl (mant) 
derivative of guanosine nucleotide mant-GppNHp, coupled at the 2‟ (3‟) hydroxyl 
group of the ribose. 
In principle, each nucleotide-binding protein has a defined intrinsic rate of nucleotide 
release, which is often too low to be physiologically relevant. Specificity and activity 
of GEFs can be analyzed qualitatively by comparison of intrinsic and GEF-
stimulated fluorescence measurements. This is performed in a fluorescence 
spectrometer (FluoroMax-4, Horiba) since these reactions are slow (>1000 sec). GEF 
and also GAP assays do not need post-translationally modified GTPases. Thus, all 
proteins and protein domains produced in Escherichia coli can be used.  
Mant-GppNHp labeled G proteins are diluted with 50mM Tris HCl (pH 7.5), 100mM 
NaCl, 5mM MgCl2 and 3mM β-Mercaptoethanol in quartz cuvettes. The intrinsic 
mant-fluorescence signal from 150nM G proteins then the signal after incubation 
with either 4µm or 200nm RasGEF1s with 10µm GDP in the fluorescence 
spectrometer was recorded real time using an excitation wavelength of 366 nm and 
an emission wavelength of 450 nm, an integration time of 2 sec at 25
 ◦
C. Data were 
fittet to a single exponential equation using grafit 5.0 (http://www.erithacus 
.com/grafit/). 
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2.12 Crystallization 
Crystallization trials were conducted in 96-well sitting-drop Qiagen 96-well 
crystallization screens (see below). These 96-well plates have room for three samples 
per well, therefore we could screen three different protein concentrations per plate, 
allowing us to test 288 conditions per trial over 70 µl well solution. A nanoliter 
liquid handling system (TTP Labtech Mosquito) was used to dispense the protein 
samples to the rooms of the wells. Crystallization trials were screened for 30 days.  
Qiagen Reservoir Solutions used for Crystallization 
1. JCSG Core I  
2. The Classics Suite  
3. JCSG + Suite  
4. The PEGS Suite  
5. AmSO4 Suite 
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3 RESULTS 
3.1 Identification of Ccdc 124 as a Ubiquitously Expressed Gene Conserved in 
Lower and Higher Eukaryotes 
3.1.1 History of Identification 
Ccdc124 was firstly identified in a study carried out by Hani Alotaibi during his 
Ph.D. studies in our group where cis-acting transcriptional regulatory elements of the 
Na
+
/I
- 
Symporter (NIS) gene were being analyzed. The aim was to determine the 
conserved non-coding regions of 3‟ downstream of the NIS gene by computational 
analysis, then assess these regions by luciferase system in order to find highly 
conserved and active regions as candidates for regulatory regions. 90 kb genomic 
DNA fragment including the NIS gene was analyzed in order to identify at least 50% 
conserved putative regulatory elements of NIS gene in human, mouse and rat. In that 
study, 10 conserved putative regions were identified via using VISTA program 
(Bary, et al., 2003 and Couronne, et al., 2003). One of these conserved regions 
(region 10)  showed a high activity in luciferase system but it came out that it was 
not a 3‟ regulatory element of NIS but it was the 5‟ regulatory region of a putative 
gene called Loc115098 (Ccdc-124).  
This gene is described as coiled-coiled domain containing 124 (Ccdc-124) in 
Genome Browser database at the University of California Santa Cruz. Ccdc-124 is 
conserved in all eukaryotes from the lower eukaryote fungus Aspergillus nidulans to 
Homo sapiens. This gene has 75% identity scores in mammals, 50% identity in 
nematodes and insects and 30-40% identity in plants and ascomycetes. Its protein has 
no domain similarities with any known protein. The gene contains 4 coding exons 
and it is predicted to encode a 223 amino acid protein in human. Molecular weight 
and isoelectric point of the protein were calculated as 25835.2 Da and 9.54, 
respectively via using ProtParam tool. It consists of 43 negatively charged, 51 
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positively charged residues, which means, 42% of the protein consists of charged 
residues (Fig.3.1).  
CLUSTAL W (1.82) Multiple Sequence Alignment for BC013949 (ccdc-124) 
 
Human(ccdc124) -MPKKFQGENTKSAAARARRAEAKA---AADAKKQKELEDAYWKDDDKHVMRKEQRKEEK 56 
Zebrafish      -MPKKFQGENSKSATARARKAEAKA---VADARKQKELEDALWEDNDKRVVKKEQRKDDK 56 
C.elegans      -MPKKFASENPKVTAARDRKATAKK---DEADKKAKATEDAKWVDNDKLNNRKMQRKEDD 56 
A.nidulans     MGGKKGGGENSKKAAGNARKAEAAANKKAIEDQKRAAEEDKQWAKGAK----SSSKKEEA 56 
                  **  .**.* ::.. *:* *         :*    **  * .. *    . .:*::  
 
Human(ccdc124) EKRRLDQLERKKETQRLLEEEDSKLKGGKAPRVATSSKVTRAQIEDTLRRDHQL-REAPD 115 
Zebrafish      ERKRLEALERKRENQRLLEEEDSKIKGKQTK--EGPSKVTRAQIEETLQSKQNV-KEIK- 112 
C.elegans      EKKREEALRRKEENRKLAEEEMSSLGNKKPAG-AATQKVTRAHIHIRKEDEERINRELEE 115 
A.nidulans     EAKKAEAARKKAERDALLAAEEASQPSKPKNNKSAAKKNAPSRGTLNLD-------QLDD 109 
               * :: :  .:* *   *   * :.  .        ..* : ::       .     :  . 
    
Human(ccdc124) TAEKAKSHLEVP---LEENVNRRVLEEGSVEARTIEDAIAVLSVAEEA-ADRHPERRMRA 171 
Zebrafish      --EKEKSHLDVP---LEENVNRIVPEEGTVEARTIEDAIAVLSTKED--LDRHPERRMKA 165 
C.elegans      KRKQEAQKIEVAGDLLVENLNKLEVEEG--EARNVDDALKVLGEEKALDDDKHPEKRMRA 173 
A.nidulans     APSSRASALNAS------------------GIDNALDALSLTSKDTSK-VDRHPERRYKA 150 
                 ..  . ::..     .. .    ...:    .  **: : .       *:***:* :* 
 
Human(ccdc124) AFTAFEEAQLPRLKQENPNMRLSQLKQLLKKEWLRSPDNPMNQRAVPFNAPK-------- 223 
Zebrafish      AYTAFEEANMPRVKMENPNMRLSQLKQQLKKEWTKSPENPLNQRAASYNTK--------- 216 
C.elegans      AYLAFEEARLPELKLNHPTFRLSQLKQILKKEWQKSPENPLNARLLALNS---------- 223 
A.nidulans     AYAAFEARRLPEIEAENPGLRRQQRIELVKKEFDKSPENPFNQVHVAFDASKEEIAAVRE 210 
                 *: ***  .:*.:: ::* :* .*  : :***: :**:**:*    . :: .         
 
Figure 3.1: High conservation of ccdc-124 gene protein sequence in eukaryotes. Protein sequences 
of ccdc124 from different eukaryotes (human, zebrafish, C. Elegans and A. nidulans) were aligned by 
using Clustal-W multiple sequence analysis program. In the figure, green shows hydroxyl and amino 
groups containing amino acids; red shows, little hydrophobic amino acids; blue shows acidic amino 
acids; pink shows alkaline amino acids. 42% of the human CCDC-124 consists of positively charged 
(K, R, H, D, E) amino acids. 
 
3.1.2 Expressional Analysis of Ccdc 124 
Northern blot analysis of Ccdc-124 was carried on a human tissue RNA transferred 
membrane (Human Blot 1, Ambion) and biotin labeled probes (Fig.3.2 and Fig.3.3).  
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Figure 3.2:  Northern blotting probes for Ccdc-124, Gapdh and β-actin. mRNA size, 5‟UTR, 
3‟UTR and probe size & location are indicated for each gene.  
According to the results of Northern Blot analysis, Ccdc-124 is ubiquitously 
expressed in all human tissues tested.  
          
Figure 3.3: Human tissue expression analysis of CCDC-124 by Northern blotting. Probes were 
labeled via biotin and hybridized to Human Blot 1 membrane (see M.M.). Blots were exposed to X-
ray films. β-actin and Gapdh were used as internal controls.   
CCDC-124 mRNA 
GAPDH mRNA 
β-ACTIN mRNA 
1         107 802            1066 
1                      265 1 147         1347 
1         73 1200                                                1793 
401                       782 
384                              792 
694                                                  1233 
381 bp probe 
408 bp probe 
539 bp probe 
5‟UTR 3‟UTR 
5‟UTR 3‟UTR 
5‟UTR 3‟UTR 
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3.2 Characterization of the protein encoded by Ccdc124 
3.2.1 Generation of polyclonal Antibody  
The 24-mer Ccdc-124 N-terminus peptide (MPKKFQGENTKSAAARARRAEAK-
[C]-amide) was synthesized by a private company (Cambridge Research 
Biochemicals) and two rabbits were been immunized by using this peptide in a KLH 
(keyhole limpet haemocyanine) conjugated form. After the 6
th
 immunization, 
reactivity towards the N-terminus peptide has been analyzed by the Company by 
Elisa analysis, and these polyclonal anti-Ccdc-124 antibodies were purified using 
affinity purification method. Then antibodies were shipped to our laboratory together 
with sufficient amounts (10 mg) of reactive peptides. 
Subsequently, we have carried out an immunoblot analysis using the antibodies 
generated aginst the N-terminus peptide of Ccdc 124. We have transfected Huh-7 
human hepatocellular carcinoma cell lines with both N- and C- terminus Flag-tagged 
versions of Ccdc 124 gene in pCMV-14 expression vectors, and then carried out a 
Western blot analysis using total proteins from these cells (see M.M.). In this 
Western blot analysis (Fig.3.4 right panel) above mentioned polyclonal Ccdc-124 
antibody have led to the detection of a 33 kD protein. This result is in agreement with 
Ccdc-124 bands obtained using Anti-flag antibodies (Fig.3.4 left panel). 
                                              
Figure 3.4: Western Blot Analysis of Ccdc-124. Left panel shows the C-terminally and N-terminally 
FLAG tagged Ccdc-124, cells were transfected either with pCMV-3XFLAG-ccdc124 (NT), pCMV-
ccdc124-3XFLAG (CT) or pCMV14 (Emp Vec) plasmids and blotting was performed with anti-
FLAG antibody; right panel shows the endogenous and over-expressed Ccdc-124 protein, cells were 
transfected with pCMV-ccdc124 (pCMV-C) plasmid and blotting was performed with above 
mentioned specific polyclonal antibody.  
40kD 
33kD 
24kD 
     CT              NT        Emp Vec pCMV-C    Emp Vec 
Anti-FLAG Anti-Ccdc-124 
Calnexin 
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3.2.2 Subcellular localization of Ccdc-124 
Immunocytochemistry is a technique used to assess the presence of a specific protein 
or antigen in cells (cultured cells, cell suspensions) by use of a specific antibody, 
which binds to it, thereby allowing visualization and examination under a 
microscope. It is a valuable tool for the determination of cellular contents from 
individual cells. Cells to be stained can be attached to a solid support like cover slips 
to allow easy handling in subsequent procedures. Cells are fixed and cell membrane 
is permeabilized with certain reagents, then proteins are first labeled with their 
specific antibody and stained with a specific secondary antibody which is conjugated 
with a fluorescent dye. 
We have assessed the presence and subcellular localizations of Ccdc-124 protein in a 
number of human cell lines. These included the ER(+) mammary tumor cell line 
model MCF-7 and a cervical cancer cell model HeLa. Cells were transfected either 
with N-Terminally FLAG tagged, C-Terminally FLAG tagged, or untagged pCMV-
Ccdc-124 plasmid. Ccdc-124 proteins were detected with either anti-FLAG antibody 
or polyclonal anti-Ccdc-124 antibody and stained with TRITC or FITC conjugated 
secondary antibody and nuclear stain was made with DAPI (Fig.3.5, Fig.3.6, Fig.3.8, 
Fig.3.9 and Fig.3.10) (see M.M.). Beside these, samples without DAPI staining were 
made in order to detect any interference of DAPI with the antibodies or the filters of 
the microscope (Fig.3.7 for HeLa cells and Fig.3.11 for MCF-7 cells). As a result of 
these experiments, it was observed that Ccdc-124 protein was mainly localized in the 
cytoplasm of the cell and ubiquitously expressed. 
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Figure 3.5: Immunocytochemistry of Ccdc-124. HeLa cells were fixed and stained with polyclonal 
anti-Ccdc-124 antibody and FITC conjugated anti-rabbit antibody. A, Endogenously expressed Ccdc-
124; B, Nuclear stain with DAPI; C, Merged image. (40X)  
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Figure 3.6: Immunocytochemistry of Ccdc-124. pCMV-Ccdc-124 transfected HeLa cells were fixed 
and stained with polyclonal anti-Ccdc-124 antibody and TRITC conjugated anti-rabbit antibody. A, 
Endogenously expressed (faint red) and transfected (bright red marked by the green rectangular line) 
Ccdc-124; B, Nuclear stain with DAPI; C, Merged image. (40X) 
 
 
 
A B 
C 
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Figure 3.7: Immunocytochemistry of Ccdc-124 without DAPI stain. pCMV-Ccdc-124 transfected 
HeLa cells were fixed and stained with polyclonal anti-Ccdc-124 antibody and TRITC conjugated 
anti-rabbit antibody without nuclear (DAPI) staining. (40X) 
    
Figure 3.8: Immunocytochemistry of Ccdc-124. pCMV-Ccdc-124-3XFLAG transfected HeLa cells 
were fixed and C terminally FLAG tagged Ccdc-124 were stained with anti-FLAG antibody and 
TRITC conjugated anti-mouse antibody. A, Transfected Ccdc-124 stain; B, Nuclear stain with DAPI; 
C, Merged image. (40X) 
A B 
C 
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Figure 3.9: Immunocytochemistry of Ccdc-124. pCMV-3XFLAG-Ccdc-124 transfected HeLa cells 
were fixed and N terminally FLAG tagged Ccdc-124 were stained with anti-FLAG antibody and 
TRITC conjugated anti-mouse antibody. A, Transfected Ccdc-124 stain; B, Nuclear stain with DAPI; 
C, Merged image. (40X) 
A B 
C 
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Figure 3.10: Immunocytochemistry of Ccdc-124. pCMV-Ccdc-124 transfected MCF-7 cells were 
fixed and stained with polyclonal anti-Ccdc-124 antibody and TRITC conjugated anti-rabbit antibody. 
A, Endogenously expressed and transfected Ccdc-124; B, Nuclear stain with DAPI; C, Merged image. 
(40X) 
 
                                      
Figure 3.11: Immunocytochemistry of Ccdc-124 without DAPI stain. pCMV-Ccdc-124 transfected 
MCF-7 cells were fixed and stained with polyclonal anti-Ccdc-124 antibody and TRITC conjugated 
anti-rabbit antibody without nuclear (DAPI) staining. (40X) 
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3.3 Identification of RasGEF1 Family Members as Proteins Interacting with 
Ccdc124 in vitro and in vivo 
3.3.1  Identification of proteins that interact with human CCDC124 by yeast two-
hybrid (Y2H) screening. 
 Bait cloning and Y2H screening were performed by Hybrigenics, S.A., Paris, France 
(http://www.hybrigenics.com). A Human Liver random-primed cDNA library, 
transformed into the Y187 yeast strain and containing ten million independent 
fragments, was used for mating. High mating efficiency was obtained by using 
specific mating method (Legrain et al., 1998, 2000, 2002). And all the fragments 
obtained from the assay gave the same result which was RasGEF1B (Fig.3.12).  
 
Figure 3.12: Yeast-two-hybrid analysis revealed RasGEF1B as a potential interaction partner of 
Ccdc-124. A human liver random primed cDNA library (in pB29 plasmid) transformed into the yeast 
Y187 strain was used for mating with the L40ΔGAl4 strain containing human Ccdc124 as a bait. 16 
positive clones have appeared on selective medium (see M.M.). All positive clones were picked, the 
corresponding prey fragments were amplified by PCR and sequenced at their 5‟ and 3‟ junctions. 
Names of positive clones were indicated (pB29_A-xx). All fragments were in frame with Gal4 
Activation Domain (IF). A in boxes indicate 99.9% confidence rate in the interaction. Start and stop 
codons of fragments that are in frame are indicated.  
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3.3.2 RasGEF1 family was validated as interacting partners of Ccdc124. 
3.3.2.1 Small Scale Protein Expressions 
Following the results obtained from yeast-two-hybrid analysis, in order to assess in 
vitro interaction capacities of Ccdc-124 and RasGEF1 family members, and validate 
the interactions between these proteins, we first expressed these proteins in bacteria 
and purified them. Ccdc-124 and RasGEF1 family proteins were cloned in an IPTG 
(isopropyl-beta-D-thiogalactopyranoside) inducible pQE81 and pQE80 E. coli 
expression system, respectively. In order to assess the best expression and 
purification conditions for pQE81L-Ccdc124, pQE80L-RasGEF1A and pQE80L-
RasGEF1B, a small scale test expression was designed. Proteins were expressed in 
bacteria growing in TB medium at two different temperatures, 16
◦
C and 23
◦
C, and 
lysed with three different lysis buffers and their corresponding wash buffers (see 
M.M.). After purification, proteins were loaded on a 15% SDS gel and stained with 
coomassie blue dye (Fig.3.13). 
 
Figure 3.13: Small scale expressions of  pQE81L Ccdc-124 in Bl21DE3 cells at 16°C and 23°C.  
“-“ and “+” stand for not induced and IPTG induced controls, “RE” stands for Raw Extract  lysate 
obtained after centrifugation not yet incubated with beads, “E” stands for Elution after incubation with  
Ni-Beads. Numbers “1,2,3” stand for three different lysis buffers (see M.M.). 
In order to be sure that the major band (see arrow in Fig.3.13) on the coomassie stain 
of Ccdc-124 is the expected band, samples were loaded to two gels, one for 
116kD 
97kD 
66kD 
45kD 
31kD 
  -      +     RE1  RE2  RE3  M     E1    E2     E3   -    +       M     RE1  RE2 RE3   E1   E2     E3 
16
◦C
 23
◦C
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coomassie and the other one for blotting with the anti-His antibody against the His 
tag of induced Ccdc-124 (Fig.3.14). 
 
Figure 3.14: Coomassie and Western Blot analysis of small scale pQE81L Ccdc-124 expression. 
“-“ and “+” stand for not induced and IPTG induced controls, “RE” stands for Raw Extract lysate 
after centrifugation but before incubation with beads, “E” stands for Elution after incubation with  Ni-
Beads. Western blot assay was performed with polyclonal anti-His-probe antibody (1:1000, Santa 
Cruz) and anti-Rabbit-Peroxidase antibody (1:2000, Sigma). Samples were obtained from cells 
incubated at 23°C (see above). 
 
Because the small scale expression and purification of pQE81L-Ccdc124 was 
successful, the large scale expression was again performed using the pQE system 
(see below). 
We then performed small scale expression and purification of RasGEF1 family 
members. According to the coomassie stainings of overnight induced RasGEF1B, the 
protein were not detected at the expected size which was approximately 57 kD (see 
arrow for the expected position of the band in Fig.3.15). For this reason in addition to 
overnight inductions, 2 hours and 3 hours inductions at 16ºC and 23ºC were also 
performed (Fig.3.16), but still no band was detected. Apart from this, a western blot 
was performed with the overnight induced samples in order to monitor once again 
the right size of RasGEF1B with anti-His antibody (Fig.3.17). According to the blot 
Immunoblot Anti-His Antibody 
    -       +       RE        E 
116kD 
97kD 
66kD 
45kD 
31kD 
Coomassie Staining  
          -       +       RE     E       M 
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results, RasGEF1B was observed at the expected size (57 kD) in the 23°C sample, 
even if it is not clearly visible in the coomassie-gel.  
 
Figure 3.15: Overnight small scale expression of pQE80L RasGEF1B in Bl21DE3 cells at 16°C 
and 23°C, respectively.  “-“ and “+” stand for uninduced and IPTG induced controls, “RE” stands for 
Raw Extract lysate after centrifugation but before incubation with beads, “E” stands for Elution after 
incubation with  Ni-Beads. “1,2,3” numbers stand for three different lysis buffers (see M.M).  The 
arrow indicate expected position of RasGEF1B band. 
 
Figure 3.16: 2 hour and 3 hour small scale expression of pQE80L RasGEF1B in Bl21DE3 cells 
at 16°C and 23°C, respectively.   “-“ and “+” stand for uninduced and IPTG induced controls, “RE” 
stands for Raw Extract lysate after centrifugation but before incubation with beads, “E” stands for 
Elution after incubation with  Ni-Beads. “2h”,”3h” and “o/n” stand for 2 hours, 3 hours and overnight, 
respectively. RasGEF1B band is again not observable. 
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Figure 3.17: Western blot analysis of pQE80L RasGEF1B with anti-Histidine antibody. “-“ and 
“+” stand for not induced and induced controls, “RE” stands for Raw Extract lysate after 
centrifugation but before incubation with beads, “E” stands for Elution after incubation with  Ni-
Beads. His-tagged RasGEF1B was detected with anti-His antibody (1:1000, Santa Cruz) and anti-
Rabbit antibody (1:2000, Sigma) 
 
It is well known that protein tags could affect the solubility of the proteins. For that 
reason, in order to assess whether His-tags could affect purification of RasGEF1 
family members, RasGEF1A and RasGEF1B inserts were taken out of the pQE 
vector system which had His tags, and they were sub-cloned into pGEX system 
which has GST tags (see M.M). In fact, pGEX system could also be a better choice 
for purification of these proteins because they are relatively more efficient in terms 
of protein expression as compared to pQE vector system. Also, GST/GSH-bead 
system based purification has advantages in terms of purification/binding efficiency 
as compared to His/Ni-Bead based systems. After cloning RasGEF1A and 
RasGEF1B into pGEX-TEV-N expression system (see M.M.), again small scale test 
expressions were performed (Fig.3.18).  
 
 -      +        RE     E         +        RE     E 
16°C                   23°C                
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Figure 3.18: Overnight small scale expression of pGEXTEVn-RasGEF1A in Bl21DE3 cells at 
16°C and 23°C, respectively.  “-“ and “+” stand for not induced and IPTG induced controls, “RE” 
stands for Raw Extract lysate after centrifugation but before incubation with beads, “E” stands for 
Elution after incubation with  GSH-Beads. – and  + signs after RE and B stand for lysis buffer with or 
without detergent (see M.M).  
Small scale expressions were performed for pGEX-RasGEF1A and 1B at 16
◦
C and 
23
◦
C with lysis buffers with or without detergent, in order to establish best buffer and 
temperature conditions for purification. The major band that was detected on the 
coomassie staining of the test expression of pGEX-RasGEF1A was ~45 kD (see 
arrow in the left panel of Fig.3.18), which normally should be ~75kD (~55kD 
RasGEF1A+~20kD GST Tag). In order to understand whether the aberrant size was 
due to an error in the sequence of the sub-cloned RasGEF1A insert, the DNA 
sequence of the insert was analyzed. Unfortunately, according to the sequencing 
results, RasGEF1A had 5 PCR generated mutations and one of them was created a 
stop codon. That result explained why the dominant band at the small scale 
expression of RasGEF1A was located at ~45 kD and not at the expected size, approx. 
75 kD. As a result, we decided to convert this mutated RasGEF1A insert to wild-type 
by site directed mutagenesis (see M.M.). After an extensive mutagenesis effort (5 
different in vitro mutagenesis PCR reactions) we were able to successfully get the 
wild-type RasGEF1A (sequencing results not shown) and continued our experiments 
with that plasmid (see below). On the other hand, pGEX-TEV-n-RasGEF1B was 
detected at right size (see arrow in right panel of Fig.3.18). As a result of these test 
200kD 
116kD 
97kD 
66kD 
45kD 
31kD 
         16°C                  23°C 
 -    +   RE+  RE-   E+  E- +   RE+ RE-  E+ E-  M 
RasGEF1A RasGEF1B 
          16°C             23°C 
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expressions, we got the best expression and purification results from 23
◦
C with the 
lysis buffer without detergent, so it was decided to proceed with that conditions.  
3.3.2.2 Large Scale Culture of CCDC-124 
5L culture of pQE81L-Ccdc-124 in BL21 E.coli cells were grown at 23
◦
C. 
Supernatant of the lysed cells were loaded to Ni-NTA-Agarose column and eluted 
with increasing concentrations of imidazole. Half of the fractions were loaded on an 
SDS-gel, and existence of Ccdc-124 protein was assessed in all fractions (Fig.3.19, 
panel A). Then, fractions containing Ccdc-124 were pooled together and 
concentrated for the gel filtration step (Fig.3.19 panel B). After gel filtration, 
fractions were loaded to an SDS gel and fractions between 27-38 and 39-51 pooled 
separately and named as pool I and pool II respectively. Pool I was used in all 
experiments, since it has a higher purity. (Fig.3.19 panel C) (see M.M.). 
Concentrations of Pool I and II are 28.8mg/ml and 30mg/ml, respectively. 
 
Figure 3.19: Purification of pQE81L-Ccdc-124. A, Fractions of ccdc-124 protein after purification 
on Ni-NTA-column were loaded on a gel; B, then fractions were collected and concentrated and 
loaded on Superdex S75 26 ⁄ 60 column and fractions coming from gel filtration were loaded on 
another gel; C,  fractions between 27 and 51 were collected in two pools and concentrated. Purified 
Ccdc-124 protein from the purer pool loaded on a gel.   
M  12   14    16   18    20     22    24  26  28  30  32   34   RE   
Ccdc-124 
27 29  31     33   35    37     39   41   43    45    47   49     51    M   RE 
A 
B 
C 
  
43 
3.3.2.3 Large Scale Culture of pGEX-RasGEF1B  
pGEX-RasGEF1B was expressed in 10L culture of E.coli, induced and collected as 
before. Supernatants were loaded on to GSH columns and fractions were loaded on a 
SDS-gel (see Fig.3.20, below). 1mg/ml TEV was used for the cleavage of the GST 
tag of pGEX-TEV-n-RasGEF1B.  
Figure 3.20:  Purification of RasGEF1B protein. Fractions of RasGEF1B protein after purification 
on GSH-column were loaded on a gel, and then selected fractions were collected for TEV cleavage. 
According to the purities of fractions observed in gels in Fig.3.20 (above), fractions 
between 1 to 19 and 53 to 57 were pooled into two tubes. Then, these two pools of 
RasGEF1B were subjected to TEV cleavage. After TEV cleavage, intensive protein 
precipitation was observed: both supernatant and the precipitated parts were loaded 
to another SDS gel and stained with coomassie blue dye (Fig.3.21). According to the 
results obtained in that gel, nearly all of the cleaved RasGEF1B proteins were 
precipitated. As a conclusion, it was decided to purify RasGEF1 proteins without 
separating them from their GST tags. 
          1     3      5       7     9     11   13    15    17   
19    
GST 
RasGEF1B 
54    56     58     60      62    64    66    68        
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Figure 3.21: TEV Cleavage of GST-RasGEF1B protein. When the GST tag is removed, 
RasGEF1B protein (see arrow) precipitated immediately. Both precipitation and the supernatant after 
TEV cleavage loaded on a gel. 
Then, the purifications were repeated by using RasGEF1B having GST tags on them 
(without TEV treatments, see Fig.3.22). Again they were pooled to two goups (Pool 
I; fractions 6-9, pool II; fractions 10-14, see Fig.3.23), and purities were monitored 
on a novel coomassie gel. Concentrated proteins were gel-filtrated and kept for the 
following experiments (see below). 
 
Figure 3.22:  Purification of RasGEF1B protein. Fractions of RasGEF1B protein after purification 
on GSH-column were loaded on a gel, and then selected fractions were collected for gel filtration. 
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Figure 3.23: Purified GST tagged RasGEF1B protein pool. After gel filtration, pools were 
concentrated and loaded on a gel, the concentration of the first pool was 14.25mg/ml (178µM) and the 
second pool was 10mg/ml (125µM).  
 
3.3.2.4 Large Scale Culture of RasGEF1A  
RasGEF1A was expressed in E. coli as a 10L culture and purified with GSH-Beads 
in two 5 ml columns (Fig.3.24 panel A). Then the elution was gel filtrated with 
Superdex S75 16/60 columns and fractions were loaded on a 15% SDS gel (Fig.3.24 
panel B). Fractions between 22-34 were collected, concentrated and concentrations 
were measured (Fig.3.24 panel C). The concentration of the protein was established 
as 8.5mg/ml (113µM). 
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Figure 3.24: RasGEF1A protein purification. A, GST-RasGEF1A was purified with GSH beads. – 
and +: uninduced and IPTG induced controls, respectively; RE: Raw Extract after lysis but before 
incubation with beads; FT: Flow Through after incubation with beads; E: Elution; M: Marker. B, 
Elution was subjected to gel filtration. Factions between 22 and 34 were collected and pooled 
together. C, Collected fractions were concentrated and loaded on a gel. 
 
3.3.3 GST Pull Down Assay 
The pull-down assay is an in vitro method used to determine physical interaction 
between proteins. A tagged protein or the bait (GST, His6, biotin etc.) purified in an 
appropriate expression system (e.g., E. coli) is immobilized on a glutathione affinity 
gel. The bait serves as the secondary affinity support for identifying new protein 
partners or for confirming a previously suspected protein partner to the bait. 
In our case, GST tagged RasGEF1A and RasGEF1B proteins were used as bait and 
Ccdc124 was used as prey. RasGEFs were alone incubated with the GSH beads in 
order to detect the level of RasGEF1 binding to the beads, or alternatively RasGEF1s 
and Ccdc124 were incubated together in order to visualize the interaction between 
RasGEF1s and Ccdc124 (Fig.3.25). GSH beads were also incubated with Ccdc124 
alone in order to detect the background interaction of Ccdc124 to the GSH beads in 
-   +   RE  FT   E    M      14 16  18   M    20    22    24   26   28    30    32   34   36   38  40 
GST-RasGEF1A 
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GST 
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C 
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the absence of GST-RasGEF1s, or GSH beads first incubated with GST protein then 
with Ccdc124 in order to detect the binding capacity of Ccdc124 to GST tag. Apart 
from these samples, RasGEF1A or 1B, Ccdc124 and GST proteins were loaded to 
the gel to determine the sizes of the proteins (Fig.3.25). As a result we have clearly 
establied that both RasGEF1A and RasGEF1B interact with Ccdc124 in vitro. This 
result validated our yeast-two-hybrid results that had initially indicated a possible 
interaction between RasGEF1s and the novel conserved eukaryotic protein of 
unknown function, Ccdc-124. 
 
Figure 3.25: GST-Pull Down Assay of GST-RasGEF1A and GST-RasGEF1B. 1a and 1b stand for 
GST-RasGEF1A and GST-RasGEF1B proteins, respectively; c stands for Ccdc-124 protein, gst 
stands for GST protein. First Lane: GST-RasGEF proteins were immobilized on GSH-Beads (which 
shows the immobilized RasGEF proteins on GSH-Beads); Second Lane: Ccdc-124 proteins were 
incubated with GSH-Beads immobilized with GST-RasGEF proteins(which shows the interaction 
between RasGEFs and Ccdc-124); Third Lane: Ccdc-124 proteins were incubated with GSH-Beads 
only (which shows the interaction capacity of Ccdc-124 with the GSH-Beads in the absence of an 
interacting partner); Fourth Lane: Ccdc-124 proteins were incubated with GSH-Beads immobilized 
with GST protein (which shows the interaction capacity of Ccdc-124 with the GST Tag); Fifth Lane: 
Marker; Sixth Lane: GST-RasGEF proteins; Seventh Lane: Ccdc-124 protein; Eighth Lane: GST 
protein. 
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3.3.4 In vitro Interaction of RasGEF1B and Ccdc-124: Polarization 
The fluorescence polarization immunoassay is another way to show in vitro 
interaction of two proteins. This method depends upon the fact that a conjugate of a 
fluorescing substance and a small molecule, moves very quickly in solution so that 
polarized light which is passed through the solution and excites the fluorescing 
substance is depolarized in the case of the emission due to the rotation of the 
conjugate taking place between impingement and emission. The degree of 
depolarization is thereby inversely proportional to the rate of rotation of the 
molecule. In the case of binding the fluorescing substance to a large molecule, for 
example in the case of binding of a fluorescent-labelled Ccdc-124(33kD) to 
RasGEF1B (75 kD), the movement of the whole conjugate is so very considerably 
limited that the polarized light is now no longer depolarized from the point of time 
when it impinges up to the point of time when it is emitted but rather again emerges 
polarized from the solution.  
We used IAEDANS as a fluorescent dye. IAEDANS is an organic fluorophore and 
stands for 5-(2-[(iodoacetyl)amino]ethylamino)naphthalene-1-sulfonic acid. It has a 
peak excitation wavelength of 336 nm and a peak emission wavelength of 490 nm. 
The extinction coefficient of the dye is 5700. It usually reacts with thiols like cystein. 
Since Ccdc-124 protein doesn‟t have any Cystein residues, it was decided to 
transform some amino-acids of Ccdc-124 into Cystein. For this purpose, I decided to 
change 3 Serins into Cysteins since their size and structures are similar. These Serins 
were selected from the coiled coil domain of the protein, because it is necessary to 
label relatively stable (inflexible) parts of the protein in order to obtain reliable 
results.  
Ser12, Ser92 and Ser156 were transformed into Cysteins by site directed 
mutagenesis. These 3 cystein mutants of Ccdc-124 proteins were purified from a 
large scale culture as before (Fig.3.26, Fig.3.27, Fig.3.28 and Fig.3.29).  
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Figure 3.26: Purification of Ser12, Ser92 and Ser156 Ccdc-124 proteins. A, Proteins were purified 
with Ni-beads. – and +: uninduced and IPTG induced controls, respectively; RE: Raw Extract after 
lysis but before incubation with beads; E: Elution.  
 
 
Figure 3.27: Elution of Ccdc-124 S12C was subjected to gel filtration. Factions between 50 and 63 
were collected and pooled together and concentrated up to 46.4 mg/ml. 
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Figure 3.28: Elution of Ccdc-124 S92C was subjected to gel filtration. Fractions between 16-25 
and 26-41 were pooled and concentrated up to 56.3 mg/ml and 67 mg/ml respectively. 
 
 
Figure 3.29: Elution of Ccdc-124 S155C was subjected to gel filtration. Fractions between 16-30 
and 31-41 were pooled and concentrated up to 58 mg/ml and 17.3 mg/ml respectively. 
 
2mg of these proteins were labeled with IAEDANS overnight and subjected to gel 
filtration in order to get rid of unlabeled proteins and free IAEDANS (Fig.3.30). 
Possible protein fractions (fractions that gave paek for 336nm for Iaedans and 280nm 
for protein at the same time) were given to gel. For every mutant, fractions around 6
th
 
fraction were pooled and concentrated. 
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Figure 3.30: Selected fractions after gel filtration for Iaedans labeling. Fractions from 2-12 from 
S12C, 3-12 for S92C, and 4-11 for S155C were collected and concentrated to 78.9µM, 89.47µM and 
87.7µM, respectively. 
These IAEDANS labeled Ccdc-124 proteins were then used for polarization assay 
with RasGEF1B protein. In this assay, the polarizations of labeled Ccdc-124 proteins 
were measured first and subsequently, RasGEF1B proteins were added with certain 
molar concentrations and with certain time laps. In normal conditions, if these two 
proteins bind together: polarization of the labeled Ccdc-124 protein changes every 
time RasGEF1B protein is added to the solution and polarization should reach to a 
saturation level when they reach to equilibration. In our case, it was obvious that 
these two proteins interact with each other because every time RasGEF1B was 
added, the polarizations were changed but since RasGEF1B was not a “happy 
protein” and precipitates easily we could not sustain that experiment long enough to 
reach saturation (Fig.3.31). 
         6       40     49      6      41      51       6      42    49    
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Figure 3.31: Polarization assay of IAEDANS labeled Ccdc-124 protein with RasGEF1B protein. 
A representative graph showing the polarization of RasGEF1B and Ccdc-124. Because of the limited 
concentration of RasGEF1B protein, assay was continued with Ccdc-124 S12C after 6µM of 
RasGEF1B.  
 
3.3.5 In Vivo Detection of Interaction between Ccdc-124 and RasGEF1B with 
Co-Immunoprecipitation 
Co-immunoprecipitation (Co-IP) is considered to be the gold standard assay for 
protein-protein interactions. The protein of interest is isolated with a specific 
antibody. The antibody-protein complex is then precipitated usually using protein-G 
or protein-A sepharose which binds most antibodies. If there are any 
protein/molecules that bind to the first protein, they will also be precipitated. Co-
precipitated protein can then be identified by Western blot analysis or by sequencing 
a purified protein band. 
Since there was no commercially available antibody of RasGEF1B, we used a C 
terminally FLAG tagged (Fig.3.32) and N terminally Myc tagged RasGEF1B 
plasmid (p3XFLAG-RasGEF1B) and anti-FLAG antibody to detect RasGEF1B 
protein.  
Ccdc124 S12C 
Ccdc124 S92C 
Ccdc124 
S155C 
2 µM IAEDANS Ccdc-
124 
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Figure 3.32: Western Blot analysis of RasGEF1B. p3XFLAG-RasGEF1B transfected HeLa cells 
were blotted with anti-FLAG antibody, equal protein loadings were assessed by blotting the same 
membrane with anti-calnexin antibody.  
  
In the first round of Co-IPs we used ANTI-FLAG
®
 M2 Affinity Gel (Sigma). 
P3XFLAG-RasGEF1B and pCMV-Ccdc-124 transfected Hela and MCF-7 cells were 
lysed and RasGEF1B protein was precipitated with ANTI-FLAG
®
 M2 Affinity Gel 
and co-precipitated Ccdc-124 protein was analyzed with its specific antibody 
(Fig.3.33). But unfortunately, the secondary antibody that was used for western blot 
also detects the dissociated heavy and light chains of the immobilized M2 antibody 
which gives around 25 and 50kDa bands (which is a common inconvenience of IP) 
and these bands partially overlap with the Ccdc-124 and RasGEF1B bands and made 
it hard to detect the bands (results not shown). 
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Figure 3.33: FLAG-IP of Hela cells. HeLa cells were co-transfected with P3XFLAG-RasGEF1B 
and pCMV-Ccdc-124, immunoprecipitated with anti-FLAG and blotted with anti-Ccdc-124.   
 
Because of the inconveniences of using secondary antibody in our system, we 
changed to c-Myc immunoprecipitation and anti-FLAG-HRP blot system. In this 
system p3XFLAG-RasGEF1B and p3XFLAG-Ccdc-124 plasmids were co-
transfected to Hela cells and RasGEF1B was precipitated with anti-c-Myc antibody, 
since it has also a Myc tag at the N terminus. And western blot was performed with 
HRP conjugated anti-FLAG antibody in order to eliminate the use of secondary 
antibody. Performing the blot with anti-FLAG-HRP also gave us the chance to 
demonstrate RasGEF1B and Ccdc-124 proteins on the same membrane at the same 
time (Fig.3.34). 
Ccdc-124 
FLAG-IP 
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Figure 3.34: Myc IP of HeLa cells with FLAG-HRP antibody. HeLa cells were co-transfected with 
P3XFLAG-RasGEF1B and p3XFLAG-Ccdc-124, immunoprecipitated with anti-MYC and blotted 
with anti-FLAG.   
 
3.3.6 Studies towards Crystalization of Ccdc-124 
Protein crystallization occurs when the concentration of protein in solution is greater 
than its limit of solubility and so the protein is in a super-saturated state. In order to 
crystallize a protein, the purified protein undergoes slow precipitation from an 
aqueous solution. As a result, individual protein molecules align themselves in a 
repeating series of "unit cells" by adopting a consistent orientation. The importance 
of protein crystallization is that it serves as the basis for X-ray crystallography, 
wherein a crystallized protein is used to determine the protein‟s three-dimensional 
structure via X-ray diffraction. Protein crystallization is inherently difficult because 
of the fragile nature of protein crystals. Proteins have irregularly shaped surfaces, 
which results in the formation of large channels within any protein crystal. 
Therefore, the non-covalent bonds that hold together the lattice must often be formed 
through several layers of solvent molecules. In addition to overcoming the inherent 
fragility of protein crystals, the successful production of x-ray worthy crystals is 
dependent upon a number of environmental factors because so much variation exists 
among proteins, with each individual requiring unique conditions for successful 
Ccdc-124 
RasGEF1B 
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crystallization. Therefore, attempting to crystallize a protein without a proven 
protocol can be very tedious. Some factors that require consideration are protein 
purity, pH, concentration of protein, temperature, and precipitants. In order for 
sufficient homogeneity, the protein should usually be at least 97% pure. pH 
conditions are also very important, as different pH‟s can result in different packing 
orientations. Buffers, such as Tris-HCl, are often necessary for the maintenance of a 
particular pH. Precipitants, such as ammonium sulfate or polyethylene glycol, are 
compounds that cause the protein to precipitate out of solution.  
Two of the most commonly used methods for protein crystallization fall under the 
category of vapor diffusion. These are known as the hanging drop and sitting drop 
methods (Fig.3.35). Both entail a droplet containing purified protein, buffer, and 
precipitant being allowed to equilibrate with a larger reservoir containing similar 
buffers and precipitants in higher concentrations. Initially, the droplet of protein 
solution contains an insufficient concentration of precipitant for crystallization, but 
as water vaporizes from the drop and transfers to the reservoir, the precipitant 
concentration increases to a level optimal for crystallization. Since the system is in 
equilibrium, these optimum conditions are maintained until the crystallization is 
complete. 
 
Figure 3.35: Diagram of sitting drop method. In this method, the protein drop sits on a pedestal 
above the reservoir solution, as opposed to hanging. This is our method of choise for obtaining 
crystals of Ccdc-124. 
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 We used sitting drop method for the crystallization of Ccdc-124 protein. 5 different, 
96 well plate reservoir solutions (Qiagen) (see M.M.) were used at 4
◦
C and 16
◦
C. 
With these solutions, three different protein concentrations can be subjected to 
crystallization at the same time. We used 10mg/ml, 20mg/ml, 30mg/ml, 40mg/ml, 
50mg/ml and 60mg/ml of protein concentrations. Reservoirs were screened for 30 
days. We use 5 different 96 well plate, which means 480 different solutions and each 
well combined with 6 different Ccdc-124 concentrations, which means 2880 samples 
and we used 2 different temperatures, which means 5760 protein crystallization 
conditions (Fig.3.36).  
Unfortunately we couldn‟t get any crystals from these experiments. It is most 
probably due to the extremely soluble structure of the protein. In order to crystallize, 
protein should precipitate first, but since Ccdc-124 protein had a high solubility we 
couldn‟t get enough precipitations even at the high concentrations such as 60mg/ml. 
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Figure 3.36: Some examples from crystallization results of Ccdc-124 out of 5760 results from 
different temperature and solution combinations.  
 
3.4 Establishment of Specificities of RasGEF1A and RasGEF1B 
N-Methyl-3„-O-anthranoyl (MANT) guanine nucleotide analogs are environmentally 
sensitive fluorescent probes, very useful to study proteins which bind guanine 
nucleotides. The ribose modification interferes minimally with the nucleotide‟s 
ability to serve as an enzyme substrate (van den Berghe et al. 1997). MANT-
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nucleotides have been used to monitor a variety of nucleotide-dependent enzyme 
functions. It has been shown that on binding to Ras the fluorescence emission of 
mant-GDP increases approximately two-fold when it binds to the protein. This 
fluorescence analogue is used to study the interaction of small G proteins with their 
guanine exchange factors. The slow time-dependent fluorescence change at 450 nm, 
when mant-GDP labeled G Protein is incubated in the presence of 100-fold excess of 
unlabeled GDP, representing the intrinsic GDP dissociation rate (Remmers et al. 
1994). 
Nucleotide exchange activities of two RasGEF1 proteins were assessed for using the 
fluorescence assay. G-proteins were loaded with fluorescent mant-nucleotide and 
incubated with RasGEF1A and RasGEF1B in the presence of a large excess of 
unlabeled nucleotide. As it has previously been shown that the stimulation of 
nucleotide dissociation by GEFs is independent of the nature of the nucleotide 
(Esters et al. 2001; Klebe et al. 1995; Lenzen et al. 1995), for reasons of stability and 
convenience mGppNHp was used in the following assays, which can be incorporated 
in the presence of alkaline phosphatase. The release of fluorescent nucleotide was 
followed as a decrease in fluorescence in real time and was fitted to a single 
exponential. To identify the specificity of RasGEF proteins, various G-proteins from 
the Ras subfamily, such as H-Ras, R-Ras, M-Ras, TC21, Di-Ras2, Rheb, RERG, 
RalB, Rap1A, Rap1B, and Rap2A were used (Colicelli 2004; Karnoub and Weinberg 
2008; Takai et al. 2001). In order to asses the role of Ccdc-124 on the GEF activity 
of RasGEF1B, Ccdc-124 protein was included to the GEF assays performed with 
RasGEF1B. 
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Figure 3.37: Guanine Nucleotide Exchange Assay of RasGEF1A on H-Ras and R-Ras. Black 
circles show the intrinsic fluorescence dissociation rate of H-Ras (150nM) by itself; Red circles show 
the effect of RasGEF1A (4µM) on the fluorescence dissociation rate of H-Ras (150nM); Blue circles 
show the intrinsic fluorescence dissociation rate of R-Ras (150nM) by itself and the Green circles 
show the effect of RasGEF1A (4µM) on the fluorescence dissociation rate of R-Ras(150nM). 
G proteins have an  intrinsic nucleotide dissociation  rate and these rates are different 
for each G protein. Guanine exchnge factors increase the nucleotide dissociation 
rates of their G protein substrates. In figure 3.37, the intrinsic nucleotide dissociation 
rates of H-Ras and R-Ras is 1.77 x 10
-4
.s
-1
 and 1.08 x 10
-3
.s
-1
 respectively.  The 
dissociation rates of H-Ras and R-Ras with RasGEF1A is 1.82 x 10
-4
.s
-1
 and 1.14 x 
10
-3
.s
-1
 respectively (Table 3.2). These rates clearly shows that RasGEF1A did not 
further stimulate the dissociation rates of these G proteins. 
 
H-RAS – R-RAS +RASGEF1A 
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Figure 3.38: Guanine Nucleotide Exchange Assay of RasGEF1A on Rap1A and M-Ras. Black 
circles show the intrinsic fluorescence dissociation rate of Rap1A (150nM) by itself; Red circles show 
the effect of RasGEF1A (4µM)  on the fluorescence dissociation rate of Rap1A (150nM); Blue circles 
show the intrinsic fluorescence dissociation rate of M-Ras (150nM)  by itself and the Green circles 
show the effect of RasGEF1A (4µM)  on the fluorescence dissociation rate of M-Ras (150nM). 
The intrinsic nucleotide dissociation rates of Rap1A and M-Ras is 1.53 x 10
-4
.s
-1
 and 
3.74 x 10
-4
.s
-1
 respectively.  The dissociation rates of Rap1A and M-Ras with 
RasGEF1A is 1.81 x 10
-4
.s
-1
 and 3.98 x 10
-4
.s
-1
 respectively (Table 3.1 and 3.2). 
These rates clearly shows that RasGEF1A did not further stimulate the dissociation 
rates of these G proteins (Fig 3.38). 
 
 
RAP1A – M-RAS + RASGEF1A 
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Figure 3.39: Guanine Nucleotide Exchange Assay of RasGEF1A on Rheb and RhebL. Black 
circles show the intrinsic fluorescence dissociation rate of Rheb (150nM)  by itself; Red circles show 
the effect of RasGEF1A (4µM)  on the fluorescence dissociation rate of Rheb (150nM); Blue circles 
show the intrinsic fluorescence dissociation rate of RhebL (150nM)  by itself and the Green circles 
show the effect of RasGEF1A (4µM) on the fluorescence dissociation rate of RhebL. (150nM) 
The intrinsic nucleotide dissociation rates of Rheb and RhebL is 3.59 x 10
-4
.s
-1
 and 
6.61 x 10
-4
.s
-1
 respectively.  The dissociation rates of Rheb and RhebL with 
RasGEF1A is 3.87 x 10
-4
.s
-1
 and 6.69 x 10
-4
.s
-1
 respectively (Table 3.2). These rates 
clearly shows that RasGEF1A did not further stimulate the dissociation rates of these 
G proteins (Fig 3.39). 
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Figure 3.40: Guanine Nucleotide Exchange Assay of RasGEF1A on Rerg and RalB. Black circles 
show the intrinsic fluorescence dissociation rate of Rerg (150nM) by itself; Red circles show the 
effect of RasGEF1A (4µM) on the fluorescence dissociation rate of Rerg (150nM); Blue circles show 
the intrinsic fluorescence dissociation rate of RalB (150nM) by itself and the Green circles show the 
effect of RasGEF1A (4µM)  on the fluorescence dissociation rate of RalB (150nM). 
The intrinsic nucleotide dissociation rates of RERG and RalB is 5.49 x 10
-3
.s
-1
 and 
9.76 x 10
-4
.s
-1
 respectively.  The dissociation rates of RERG and RalB with 
RasGEF1A is 6.05 x 10
-3
.s
-1
 and 9.53 x 10
-4
.s
-1
 respectively (Table 3.2). These rates 
clearly shows that RasGEF1A did not further stimulate the dissociation rates of these 
G proteins (Fig 3.40). 
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Figure 3.41: Guanine Nucleotide Exchange Assay of RasGEF1A on Rap1B and DiRas2. Black 
circles show the intrinsic fluorescence dissociation rate of Rap1B (150nM) by itself; Red circles show 
the effect of RasGEF1A (4µM) on the fluorescence dissociation rate of Rap1B (150nM); Blue circles 
show the intrinsic fluorescence dissociation rate of DiRas2 (150nM) by itself and the Green circles 
show the effect of RasGEF1A (4µM) on the fluorescence dissociation rate of DiRas2 (150nM). 
The intrinsic nucleotide dissociation rates of Rap1B and DiRas2 is 5.64 x 10
-5
.s
-1
 and 
1.92 x 10
-3
.s
-1
 respectively.  The dissociation rates of Rap1B and DiRas2 with 
RasGEF1A is 4.69 x 10
-5
.s
-1
 and 1.99 x 10
-3
.s
-1
 respectively (Table 3.1 and 3.2). 
These rates clearly shows that RasGEF1A did not further stimulate the dissociation 
rates of these G proteins (Fig 3.41). 
The rate of nucleotide release from Rap2A in the presence of 4 µM RasGEF1A was 
too fast to detect, for this reason different concentrations of RasGEF1A were tested 
on Rap2A (Fig.3.42) and according to these results 200 nm of RasGEF1A was 
chosen to use in the experiments.   
 
 
Figure 3.42: RasGEF1A concentrations on Rap2A. Because of the effect of 4µM RasGEF1A was 
too fast to detect its effect on Rap2A, different concentrations of RasGEF1A were tested on Rasp2A 
in order to asses the best concentration for RasGEF1A.  Black circles show the intrinsic fluorescence 
dissociation rate of Rap2A (150nM) by itself; Red circles show the effect of 100nM RasGEF1A, blue 
circles show the effect of 200nM RasGEF1A and green circles show the effect of 400nM RasGEF1A 
on the fluorescence dissociation rate of Rap2A (150nM).  The Concentration of 200nM was chosen.   
Rap2A 
Rap2A + 100nM GEF1A 
Rap2A + 200nM GEF1A 
Rap2A + 400nM GEF1A 
RasGEF1A Concentrations 
  
65 
 
Figure 3.43: Guanine Nucleotide Exchange Assay of RasGEF1A with Ccdc-124 on Rap2A. Black 
circles show the intrinsic fluorescence dissociation rate of Rap2A (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) (10 times the concentration of GEF) on the fluorescence 
dissociation rate of Rap2A (150nM); Red circles show the effect of RasGEF1A (200nM) on the 
fluorescence dissociation rate of Rap2A (150nM); Blue circles show the effect of RasGEF1A 
(200nM) together with Ccdc-124 (40µM) on the fluorescence dissociation rate of Rap2A (150nM).  
Figure 3.43 shows the GEF activity of RasGEF1A on Rap2A and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of Rap2A is 
2.02 x 10
-5
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 3.78 x 10
-5
.s
-1
 The dissociation rate of Rap2A with RasGEF1A is 1.82 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
2.12 x 10
-4
.s
-1
  (Table 3.1). These results indicate that RasGEF1A stimulate the 
nucleotide dissociation of Rap2A but Ccdc-124 does not further stimulate or inhibit 
this effect. 
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Figure 3.44: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on R-Ras. Black 
circles show the intrinsic fluorescence dissociation rate of R-Ras (150nM)  by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of R-Ras (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of R-Ras (200nM); 
Blue circles show the effect of RasGEF1B (4µM)  together with Ccdc-124 (40µM)  on the 
fluorescence dissociation rate of R-Ras (150nM).  
Figure 3.44 shows the GEF activity of RasGEF1B on R-Ras and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of R-Ras is 
1.08 x 10
-3
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 9.50 x 10
-4
.s
-1
 The dissociation rate of R-Ras with RasGEF1B is 9.03 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
9.37 x 10
-4
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of R-Ras and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of R-Ras. 
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Figure 3.45: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on H-Ras. Black 
circles show the intrinsic fluorescence dissociation rate of H-Ras (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of H-Ras (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of R-Ras (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of H-Ras (150nM).  
Figure 3.45 shows the GEF activity of RasGEF1B on H-Ras and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of H-Ras is 
1.77 x 10
-4
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 1.73 x 10
-4
.s
-1
 The dissociation rate of H-Ras with RasGEF1B is 1.74 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
1.73 x 10
-4
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of H-Ras and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of H-Ras. 
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Figure 3.46: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on M-Ras. Black 
circles show the intrinsic fluorescence dissociation rate of M-Ras (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of M-Ras (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of M-Ras (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of M-Ras (150nM).  
Figure 3.46 shows the GEF activity of RasGEF1B on M-Ras and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of M-Ras is 
3.74 x 10
-4
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 3.83 x 10
-4
.s
-1
 The dissociation rate of M-Ras with RasGEF1B is 3.70 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
3.66 x 10
-4
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of M-Ras and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of M-Ras. 
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Figure 3.47: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on Rheb. Black 
circles show the intrinsic fluorescence dissociation rate of Rheb (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of Rheb (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of Rheb (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of Rheb (150nM).  
Figure 3.47 shows the GEF activity of RasGEF1B on Rheb and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of Rheb is 
3.59 x 10
-4
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 3.46 x 10
-4
.s
-1
 The dissociation rate of Rheb with RasGEF1B is 3.46 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
3.58 x 10
-4
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of Rheb and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of Rheb. 
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Figure 3.48: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on RhebL. Black 
circles show the intrinsic fluorescence dissociation rate of RhebL (150 nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of Rheb (150 nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of RhebL (150 nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of RhebL (150 nM).  
Figure 3.48 shows the GEF activity of RasGEF1B on RhebL and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of RhebL is 
1.44 x 10
-5
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 1.90 x 10
-5
.s
-1
 The dissociation rate of RhebL with RasGEF1B is 1.70 x 10
-
5
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
2.00 x 10
-5
.s
-1
. These results clearly shows that RasGEF1B does not stimulate the 
nucleotide dissociation of RhebL and Ccdc-124 does not have a further effect on the 
nucleotide dissociation rates of RhebL. 
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Figure 3.49: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on RalB. Black 
circles show the intrinsic fluorescence dissociation rate of RalB (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of RalB (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of RalB (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of RalB (150nM).  
Figure 3.49 shows the GEF activity of RasGEF1B on RalB and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of RalB is 
9.76 x 10
-4
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 9.66 x 10
-4
.s
-1
 The dissociation rate of RalB with RasGEF1B is 9.46 x 10
-4
.s
-
1
 and once more the rate was not significantly changed with Ccdc-124 which is 9.32 
x 10
-4
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not stimulate 
the nucleotide dissociation of RalB and Ccdc-124 does not have a further effect on 
the nucleotide dissociation rates of RalB. 
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Figure 3.50: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on Rerg. Black 
circles show the intrinsic fluorescence dissociation rate of Rerg (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of Rerg (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of Rerg (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of Rerg (150nM).  
Figure 3.50 shows the GEF activity of RasGEF1B on Rerg and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of Rerg is 
5.49 x 10
-3
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 7.69 x 10
-3
.s
-1
 The dissociation rate of Rerg with RasGEF1B is 5.37 x 10
-3
.s
-
1
 and once more the rate was not significantly changed with Ccdc-124 which is 4.55 
x 10
-3
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not stimulate 
the nucleotide dissociation of Rerg and Ccdc-124 does not have a further effect on 
the nucleotide dissociation rates of Rerg. 
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Figure 3.51: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on Rap1B. Black 
circles show the intrinsic fluorescence dissociation rate of Rap1B (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of Rap1B (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of Rap1B (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of Rap1B (150nM).  
Figure 3.51 shows the GEF activity of RasGEF1B on Rap1B and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of Rap1B is 
5.64 x 10
-5
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 5.90 x 10
-5
.s
-1
 The dissociation rate of Rap1B with RasGEF1B is 5.66 x 10
-
5
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
5.32 x 10
-5
.s
-1
  (Table 3.1). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of Rap1B and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of Rap1B. 
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Figure 3.53: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on DiRas2. 
Black circles show the intrinsic fluorescence dissociation rate of DiRas2 (150nM) by itself; the Green 
circles show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of DiRas2 (150nM); 
Red circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of DiRas2 
(150nM); Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the 
fluorescence dissociation rate of DiRas2 (150nM).  
Figure 3.45 shows the GEF activity of RasGEF1B on DiRas2 and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of DiRas2 
is 1.92 x 10
-3
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 1.97 x 10
-3
.s
-1
 The dissociation rate of DiRas2 with RasGEF1B is 1.86 x 10
-
3
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
1.77 x 10
-3
.s
-1
  (Table 3.2). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of DiRas2 and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of DiRas2. 
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Figure 3.54: Guanine Nucleotide Exchange Assay of RasGEF1B with Ccdc-124 on Rap2A. Black 
circles show the intrinsic fluorescence dissociation rate of Rap2A (150nM) by itself; the Green circles 
show the effect of Ccdc-124 (40µM) on the fluorescence dissociation rate of Rap2A (150nM); Red 
circles show the effect of RasGEF1B (4µM) on the fluorescence dissociation rate of Rap2A (150nM); 
Blue circles show the effect of RasGEF1B (4µM) together with Ccdc-124 (40µM) on the fluorescence 
dissociation rate of Rap2A (150nM).  
Figure 3.54 shows the GEF activity of RasGEF1B on Rap2A and the effect of Ccdc-
124 protein on this stimulation. The intrinsic nucleotide dissociation rate of Rap2A is 
2.02 x 10
-5
.s
-1
 and this rate was not significantly changed by addition of Ccdc-124 
which is 1.17 x 10
-5
.s
-1
 The dissociation rate of Rap2A with RasGEF1B is 1.79 x 10
-
4
.s
-1
 and once more the rate was not significantly changed with Ccdc-124 which is 
1.83 x 10
-4
.s
-1
  (Table 3.1). These results clearly shows that RasGEF1B does not 
stimulate the nucleotide dissociation of Rap2A and Ccdc-124 does not have a further 
effect on the nucleotide dissociation rates of Rap2A. 
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most tested Ras family members, such as H-Ras, R-Ras, M-Ras, TC21, Di-Ras2, 
Rheb, RERG, or RalB (Fig.3.37 to 3.56). However, both RasGEF1A and RasGEF1B 
RAP2A + RASGEF1B + CCDC-124 
Rap2A 
Rap2A+ GEF1B 
Rap2A+ GEF1B + Ccdc-124 
Rap2A+ Ccdc-124 
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stimulated exchange on Rap2A (Fig.3.42, Fig.3.43 and Fig.3.54), whereas they had 
no GEF activities on the other members of the Rap subfamily, Rap1A or Rap1B, 
demonstrating that the RasGEF1 family members show a similar specificity. 
However, the presence of Ccdc-124 protein in the exchange assay did not affect 
exchange rate of any G-protein neither with RasGEF1A nor with RasGEF1B 
(Fig3.43 to Fig.3.54).  
 
Although the concentration of RasGEF1A was reduced 20 times, the rate of 
nucleotide release from Rap2A (1.82 x 10
-4
.s
-1
) was only comparable to the rate of 
release stimulated by RasGEF1B (1.79 x 10
-4
.s
-1
), indicating a higher activity of 
RasGEF1A than of RasGEF1B. Altogether, these results clearly indicated that both 
RasGEF1A and RasGEF1B belong to a novel class of RapGEFs that are specific for 
Rap2.  
Representative fluorescence traces for the RasGEF1A and RasGEF1B reactions are 
shown in Table.3.1 and Table 3.2 and the experiments are summarized in Fig.3.55. 
Figure 3.56 shows the effects of RasGEF1A and RasGEF1B on Rap family of 
proteins. 
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  Intrinsic 
RasGEF1A 
(200 nM) 
RasGEF1B 
(4 µM) 
Rap1a wt  1.53e-004  1.81e-004  1.34e-004 
Rap1b wt  5.64e-005  4.69e-005  5.66e-005 
Rap1b S39F  5.29e-005  6.15e-005  1.80e-004 
Rap2A wt  2.02e-005  1.82e-004  1.79e-004 
Rap2A T27I  1.30e-005  1.03e-004  8.75e-005 
Rap2A F39S  2.27e-005  2.71e-005  2.86e-005 
Rap2A S66A  2.51e-005  2.59e-004  2.65e-004 
Table 3.1: Representative nucleotide exchange rates of Rap1 and Rap2 proteins and their mutant 
forms with RasGEF1A and RasGEF1B.  
  Intrinsic RasGEF1A RasGEF1B 
H-Ras  1.77e-004  1.82e-004  1.74e-004 
R-Ras  1.08e-003  1.14e-003  9.03e-004 
M-Ras  3.74e-004  3.98e-004  3.70e-004 
TC21  7.17e-004  7.17e-004  6.96e-004 
RalB  9.76e-004  9.53e-004  9.G46e-004  
Rheb  3.59e-004  3.87e-004  3.46e-004 
Di-Ras2  1.92e-003   1.99e-003  1.86e-003 
RERG  5.49e-003  6.05e-003  5.37e-003 
Table 3.2: Representative nucleotide exchange rates of Ras family of G proteins with RasGEF1A 
and RasGEF1B. 
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Figure 3.55:  Guanine nucleotide exchange rates of Ras family of G-proteins in the presence of 
RasGEF1A and RasGEF1B. G-proteins indicated in each set of bar graphs were loaded with mant-
GNP, and dissociation of the fluorescent nucleotide in the absence (intrinsic rate) or in the presence of 
200nM RasGEF1A or 4µM RasGEF1B were followed. Values were obtained from at least three 
independent experiments, and representative graphs are displayed. GEF1A and GEF1B stand for 
RasGEF1A and RasGEF1B, respectively.  
 
Figure 3.56: Guanine nucleotide exchange assays of Rap family of G-proteins in the presence of 
RasGEF1A and RasGEF1B. G-proteins were loaded with mant-GNP and guanine nucleotide 
exchange reaction of 150nM Rap2A, Rap1A and Rap1B with 200nM RasGEF1A (A) and with 4µM 
RasGEF1B (B). Dark Red circles show the intrinsic fluorescence dissociation rate of Rap2A by itself; 
Red circles show the effect of RasGEFs on the fluorescence dissociation rate of Rap2A; Dark Blue 
circles show the intrinsic fluorescence dissociation rate of Rap1A by itself; Light Blue circles show 
the effect of RasGEFs on the fluorescence dissociation rate of Rap1A; Dark Green circles show the 
intrinsic fluorescence dissociation rate of Rap1B by itself; Light Green circles show the effect of 
RasGEFs on the fluorescence dissociation rate of Rap1B; 
 
A B 
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3.5 Mutational Analysis of RasGEF1/Rap2 Interaction and Determination of 
Phe 39 as a specification residue. 
Rap1A, Rap1B and Rap2A are closely related proteins. Their switch I region (amino 
acids 25–40) and switch II region (amino acids 57–75), both of which were 
previously shown to contain critical residues for G-protein–GEF 
interactions(Boriack-Sjodin et al. 1998; Rehmann et al. 2008; van den Berghe et al. 
1999), are nearly identical. In an effort to identify residues that are critical for the 
specificity of RasGEF1A and RasGEF1B interactions with Rap2, the switch I and 
switch II regions of Rap proteins were compared and residues that are localized in 
these conserved functional domains, but differ between the two G-proteins were 
identified(Fig.3.57). In parallel, by taking advantage of a previously solved structure 
of Rap1B in complex with Epac2 (Rehmann et al. 2008), a structural model was 
prepared in order to detect residues in Rap2A that are distinct from their counterparts 
in Rap1A and Rap1B and are expected to interact with RasGEF1s (Fig. 3.58). The 
predominant part of the interface between Rap2A and RasGEF1B includes conserved 
regions of the GEF protein, with the exception of two regions that are in close 
contact with the G-protein but do not show sequence conservation. The first region 
includes the interface for binding to the switch I region of Rap2A, and the second is 
located around helix α 2 of Rap, C-terminal of the switch II region (Fig.3.58).  The 
contact area around the switch II region of Rap is conserved between RasGEF1B and 
Epac2. The only switch I residue that is not conserved between Rap1 and Rap2 is 
Phe39 (Rap2A), which corresponds to Ser39 inRap1B (Fig.3.57). The side chain of 
Ser39 is encircled by the switch I region (Fig.3.58) suggesting that Phe39 of Rap2 
will cause an entirely different conformation of this loop region. Interestingly, this 
region is not conserved between RasGEF1B and Epac2. Helix α2 of Rap is in direct 
contact with an α-helix in Epac2 that is remodeling the switch II region for the GEF 
reaction. This interaction mostly depends on the main chain of Epac2, and the only 
side chain interaction is established by Ser66 (Rap2A), which is an Ala (Ala66) in 
Rap1B (Fig.3.57 and Fig.3.58). Therefore, Phe39 and Ser66 in Rap2 were identified 
as possible discriminatory candidates for the G-protein–GEF interaction. A third 
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possible candidate was Thr27 in Rap2A, as this hydrophilic residue was replaced 
with a hydrophobic Ile in Rap1B, and structural data indicated this residue to be in 
contact with a conserved region of Epac2 (Fig.3.58).  
 
 
 
 
Figure 3.57: Positions of residues selected for mutational analysis. Sequence alignment of H-Ras, 
Rap1A, Rap1B, Rap2A, Rap2B and Rap2C. Residues that have 100%, 80% and 60% similarity are in 
dark blue, blue and gray, respectively. Thr27, Phe39, and Ser66, chosen for mutational analysis, are 
indicated by blue boxes and an asterisk below.  
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Figure 3.58: Predictive model of a Rap2A–RasGEF1B complex. The sequence of RasGEF1B was 
overlain with Epac2 from the Rap1B–Epac2–cAMP complex (Protein Data Bank code: 3CF6 
(Rehmann et al. 2008), using MODELLER software (Marti-Renom et al. 2000), remodeling flexible 
loops and sequence differences caused by gaps in sequence alignment. Residues that were different 
between Rap1B and Rap2A were mutated in Rap1B–Epac2–cAMP by using COOT software (Emsley 
and Cowtan 2004). Sequence differences between Rap2A and Rap1B are highlighted in magenta; the 
secondary structure of Rap1B is in yellow. Switch I (green), switch II (cyan) and P-loop (red) regions 
are indicated. RasGEF1B is shown as a gray surface with conserved residues (as compared with 
Epac2) in blue, and interface residues that are not conserved in light brown. 
 
 
We then carried out a comparative mutational analysis of the interaction between 
RasGEF1 and Rap proteins by converting Thr27, Phe39 and Ser66 in Rap2 to the 
residues found at the same positions in Rap1. Rap2 proteins carrying T27I, F39S and 
S66A mutations were expressed (Fig.3.59). 
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Figure 3.59: Purifications of Rap2A T27I, Rap2A S66A and Rap2A F39S proteins. Three Rap2A 
mutants were purified with GSH-Beads and GST tags were cleaved with Thrombin on the column and 
it is named as E1, then the residual proteins left on the column collected with elution buffer and 
named as E2 . – and +: uninduced and IPTG induced controls, respectively; RE: Raw Extract after 
lysis but before incubation with beads; FT: Flow Through after incubation with beads; E: Elution, M: 
Marker. 
After GSH purifications of Rap2A mutants, eluates were controlled with HPLC to 
verify the presence of Rap proteins but not GST, since they have nearly the same 
size. The logic of distinguishing the Rap proteins from the GST proteins is: Rap 
proteins are naturally bound to nucleotides like GMP, GDP and GTP but mostly they 
are found as GDP bound. If the eluates contain Rap proteins instead of GST protein, 
they should preserve free nucleotides in the solution after proteins are precipitated 
with heat. For that purpose, 100µM of each protein eluate was prepared in 25µl H2O 
and proteins were precipitated by heating the samples at 95 
◦
C, after the removal of 
the precipitated proteins by centrifugation, supernatants were subjected to HPLC 
after a control run with GDP. According to these HPLC results, all eluates had high 
concentrations of GDP which is the indicator of the presence of Rap proteins 
(Fig.3.60, Fig3.61 and Fig.3.62). 
 T27I                                           S66A                       
        -    +    RE  FT E1  E2    M    -    +    RE FT  
E1  E2 
F39S                                                  
     -        +       RE  FT    E1     E2        M 250 
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95 
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Figure 3.60: HLPC reaction of Rap2A S66A. 100µM purified Rap2A S66A was subjected to HPLC 
reaction to measure the concentrations of nucleotides in order to confirm the presence of the GTP 
binding protein Rap2A.    
 
Figure 3.61: HLPC reaction of Rap2A T27I. 100µM purified Rap2A T27I was subjected to HPLC 
reaction to measure the concentrations of nucleotides in order to confirm the presence of the GTP 
binding protein Rap2A.    
Rap2A T27I 
GDP 
Rap2A S66A  
GDP 
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Figure 3.62: HLPC reaction of Rap2A F39S. 100µM purified Rap2A F39S was subjected to HPLC 
reaction to measure the concentrations of nucleotides in order to confirm the presence of the GTP 
binding protein Rap2A.    
 
After these controls, 2mg from each Rap2A mutant protein was subjected to mant-
GppNHp exchange with alkaline phosphatase and another round of HPLC analysis 
was performed to control the exchange reaction (data not shown). Subsequently, 
mant-GppNHp exchanged Rap2A mutant proteins were subjected to gel filtration in 
order to get rid of unlabelled proteins. Possible fractions were loaded on an SDS gel 
(Fig.3.63) and positive fractions from each sample were pooled together and 
concentrated. The presence of mant-GppNHp was tested again with HPLC (Fig.3.64, 
Fig3.65, Fig.3.66 and Fig3.67).  
Rap2A F39S 
GDP 
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Figure 3.63: Gel filtrations of Rap2A T27I, S66A and F39S proteins after mGppNHp exchange 
raection. Fractions between 20-25 from S66A, 26-32 from T27I and 14-19 from F39S were collected 
and concentrated up to 2.81 mg/ml, 2.6mg/ and 3.2mg/ml respectively.  
 
 
Figure 3.64: Mant-GppNHp retention time on HPLC. A standart m-GppNHp control sample was 
run on HLPC to determine the retention time of m-GppNHp which was  around 3 min. 
Standart Mant-GppNHp Peak 
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Figure 3.65: Mant-GppNHp retention time of Rap2A S66A on HPLC. 100µM Mant-GppNHp 
loaded Rap2A S66A protein was run on HPLC to verify the exchange reaction and to determine the 
concentration of loaded protein. 
 
Figure 3.66: Mant-GppNHp retention time of Rap2A T27I on HPLC. 100µM Mant-GppNHp 
loaded Rap2A T27I protein was run on HPLC to verify the exchange reaction and to determine the 
concentration of loaded protein. 
 
Rap2A T27I After Exchange and Gel filtration 
M-GppNHp 
Rap2A S66A After Exchange and Gel filtration 
M-GppNHp 
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Figure 3.67: Mant-GppNHp retention time of Rap2A F39S on HPLC. 100µM Mant-GppNHp 
loaded Rap2A F39S protein was run on HPLC to verify the exchange reaction and to determine the 
concentration of loaded protein. 
These mant-GppNHp labeled Rap2A mutants then subjected to GEF assay with 
RasGEF1 family of proteins in order to analyze the discriminatory amino acids. 
According to the GEF assay results, mutating Ser66 in the switch II region of Rap2 
did not affect exchange rates by RasGEF1s (Fig.3.68), even though this region was 
previously shown to contain residues important for G-protein-GEF interactions 
(Mistou et al. 1992; Mosteller et al. 1995; Quilliam et al. 1996). Mutation T27I in 
the switch I region of Rap2 slowed down the exchange in the presence of RasGEF1s 
(Fig.3.68) but the effect was also small. Clearly, the most dramatic effect was 
obtained by mutating residue 39 of Rap2, which completely abolished nucleotide 
exchange of Rap2(F39S) catalyzed by RasGEF1A or RasGEF1B (Fig.3.68), 
indicating that Phe39 is essential for the catalytic interaction of Rap2 with RasGEF1 
family members. 
 
Rap2A F39S After Exchange and Gel 
filtration 
M-GppNHp 
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Figure 3.68: Guanine nucleotide exchange rates of wild-type and mutant Rap2A proteins. Wild-
type or mutant Rap2A proteins were loaded with fluorescent mant-GNP, and the release of nucleotide 
was measured in real time in the absence or presence of GEFs. Values were obtained from at least 
three independent experiments, and representative graphs are displayed. (A) Guanine nucleotide 
exchange reaction of 150 nM wild-type Rap2A, Rap2A(F39S), Rap2A(S66A) and Rap2A(T27I) with 
200 nM RasGEF1A. (B) Guanine nucleotide exchange reaction of 150 nM wild-type Rap2A, 
Rap2A(F39S), Rap2A(S66A) and Rap2A(T27I) with 4 µM RasGEF1B.  
 
In order to assess whether simply converting the residue at the same position in Rap1 
to Phe (as in Rap2A) could lead to the stimulation of exchange by RasGEF1 family 
members, Ser39 in Rap1 was mutated to Phenylalanine by site directed mutagenesis, 
expressed in E.coli and  purified with GSH beads. In our first trial, we tried to 
remove the GST tag on the column but most of the protein precipitated, that is why 
in our second trial we made 3 different elutions; first elution was made with 
glutathione buffer without thrombin cleavage (in order to have a backup GST tagged 
protein in case of the other elutes precipitate), second elution was made with 
glutathione buffer and then elution was subjected to thrombin cleavage and in the 
third one, thrombin was added directly to the GSH column (Fig.3.69). Since the 
second elute had enough Rap1B S39F protein, we continued to mGppNHp exchange 
with that elute, and then exchange was controlled with HPLC as before (Fig.3.70). 
A B 
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Figure 3.69: Purification of Rap1B S39F protein. Rap1B S39F mutant was purified with GSH-
Beads and GST tags were cleaved with Thrombin. – and +: uninduced and IPTG induced controls, 
respectively; RE: Raw Extract after lysis but before incubation with beads; FT: Flow Through after 
incubation with beads; E1: Elution with glutathion buffer without thrombin cleavage; E2: Elution with 
glutathion buffer, then cleavage with thrombin; E3: Thrombin cleavage on the column; M: Marker.  
 
Figure 3.70: Mant-GppNHp retention time of Rap1B S39F on HPLC. 100µM Mant-GppNHp 
loaded Rap1B S39F protein was run on HPLC to verify the exchange reaction and to determine the 
concentration of loaded protein. 
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Subsequently, the guanine nucleotide exchange (GEF) activities of RasGEF1s on 
mutant Rap1(S39F) were tested (Fig.3.71). Interestingly, we observed that even 
though having Phe instead of Ser at position 39 of Rap1 was not sufficient for 
RasGEF1A to stimulate nucleotide exchange of Rap1(S39F), RasGEF1B could 
stimulate the exchange of mutant Rap1(S39F), albeit at a slower rate than that of 
Rap2 (Fig.3.71). However, RasGEF1A could not stimulate the exchange of mutant 
Rap1(S39F). In order to assure that RasGEF1A can not stimulate the exchange, 
increasing concentrations of RasGEF1A (up to 20 µM which is 200 times higher 
than the concentrations used for the other GEF assays) was used for the GEF assay of 
RasGEF1A with Rap1(S39F) (Fig.3.72). Even though the concentrations of 
RasGEF1A was increased to 20 µM, Rap1B(S39F) exchange did not affected 
(Fig.3.72). These results indicate that Phe39 is not only essential for stimulation of 
Rap2 by the RasGEF1 family of exchange factors, but is also sufficient, at least 
partially, for the specificity between Rap1 and Rap2 and for RasGEF1B to act as a 
cognate GEF on Rap1. 
 
 
Figure 3.71: Guanine nucleotide exchange rates of wild-type and mutant Rap1B proteins. Wild-
type or mutant Rap1B proteins were loaded with fluorescent mant-GNP, and the release of nucleotide 
was measured in real time in the absence or presence of GEFs. Values were obtained from at least 
three independent experiments, and representative graphs are displayed. (A) Guanine nucleotide 
exchange reaction of 150 nM wild-type Rap1B and Rap1B(S39F) with 200 nM RasGEF1A. (B), with 
4 µM RasGEF1B.  
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Figure 3.72: Guanine nucleotide exchange (GEF) assay results of increasing concentrations of 
RasGEF1A on Rap1B(S39F). 150 nM Rap1B(S39F) loaded with mGppNHp were subjected to GEF 
assay in the absence (black circles) and in the presence of 5 µM (red circles), 10 µM (blue circles) and 
20 µM (green circles) RasGEF1A. 
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4 DISCUSSION 
The promoter of Ccdc-124 was identified in an unrelated study, and intrigued by 
high conservation rates of this gene in eukaryotes we decided to study cellular 
functions of this protein. The gene was found in fission yeast Schizosaccharomyces 
pombe and in a homothallic fungal mold Aspergillus nidulans, however it is absent in 
the genome of the budding yeast model Saccharomyces cerevisiae (Fig. 3.1, and 
results not shown). It could be speculated that Ccdc-124 could have a role in 
cytokinesis which is mechanistically different in S. cerevisiae (budding) as compared 
to other eukaryote models (fission/central division). As shown in Fig 3.1 and 
presented in corresponding section in “Results”, Ccdc-124 is conserved with an 
impressive rate among all eukaryotes, and we assumed that these high conservation 
rates reflect its basic cellular functions. An initial screening of a cDNA library 
originated from mRNAs obtained from human liver cells by using Ccdc-124 as a bait 
in a yeast-two-hybrid platform (performed in collaboration with Hybrigenics S.A., 
Paris, France) have only revealed RasGEF1B as its potential interaction partner. We 
have then validated these results by two different experimental methods such as 
GST-pull down assays (Fig.3.25) and by co-immunoprecipitation experiments 
(Fig.3.33 and Fig.3.34). RasGEF1A, another member of RasGEF1 family was also 
included in these experiments (Fig.3.25). Both of these in vitro and in vivo (cell 
culture) analytic methods have further revealed an interaction of Ccdc-124 with 
RasGEF1 family members.  
The cellular functions of RasGEF1 proteins were not sufficiently studied, and they 
were not appropriately established. There were only two studies that have addressed 
RasGEF1 family members: A multiple human tissue northern blot analysis carried 
out by Ura et al. (Ura et al. 2006) revealed that brain and spinal cord are two tissues 
with very strong RasGEF1A expression. These authors reported that RasGEF1A 
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could act as a GEF for H-Ras, K-Ras, and N-Ras, but sufficient experimental details 
were not given, and nor were other Ras proteins tested in comparison (see below). 
Regarding RasGEF1B, in fact the gene encoding murine RasGEF1B was first 
identified in a study reporting upregulation of its expression in macrophages in 
response to mucin-like glycoproteins of a protozoan parasite, Trypanosoma cruzi, 
and it was initially named GPIc4 (Ferreira et al. 2002). A study on tissue-specific 
expression of RasGEF1B homolog in developing zebrafish embryos indicated that 
this gene is strongly expressed in midbrain and hindbrain tissues (Epting et al. 2007). 
No other functional studies were carried out on this family of GEFs. In frame of this 
thesis work, we have expressed and purified Ccdc-124, RasGEF1A, RasGEF1B, as 
well as mutant forms of Rap2A and Rap1B in bacteria, and in collaboration with the 
group of Prof. Alfred Wittinghofer at Max-Planck Institute for Structural Biology we 
have, on one hand systematically tested stimulatory potentials of RasGEF1 family 
members on guanine nucleotide exchange in a large set of Ras superfamily of G 
proteins, and on the other hand assessed a possible effect of Ccdc-124 on the 
activities of RasGEF1 family members. As a result of these in vitro analysis using 
purified proteins we have unequivocally shown for the first time that RasGEF1A and 
RasGEF1B are specific for Rap2, and they do not activate nucleotide exchange of the 
other member of Rap family, Rap1 (see below for a longer discussion of these 
results). However, we could not identify any function of Ccdc-124 on GEF activities 
in this in vitro experimental set-up (Fig.3.43 and Fig.3.54). This result does not 
necessarily mean non-functionality of Ccdc-124 in RasGEF1 stimulated GDP/GTP 
exchange of Rap2. In fact, previous analysis carried out by Serap Erkek during her 
Master‟s project in our laboratory revealed that Ccdc-124 contains several potential 
phosphorylation sites (Thr, Ser, or Tyr), and it is possible that these modifications 
could modulate the functions of the protein. This might be reason why in an 
experimental set-up involving bacteria purified proteins, functionality of Ccdc-124 
may remain unnoticed. It may however affect the function or kinetic parameters of 
RasGEF1 family of proteins in response to extracellular ligands, or the intracellular 
environment in a living cell system. 
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Purification of His-tagged Ccdc-124 turned out to be without major problems. We 
have purified ample amounts for GEF assays, as well as for crystallization purposes. 
Furthermore, aliquots of purified Ccdc-124 were sent to the laboratory at Bilkent, 
and mice were injected (50 µg/animal/immunization) with purified proteins in an 
effort to generate monoclonal antibodies against Ccdc-124 (Irem Gürbüz and Uygar 
Tazebay, personal comm.). However, purification of His-tagged RasGEF1B were 
rather unefficient. It is well known that expression systems and tags can affect the 
expression and purification efficiencies. For that reason, RasGEF1A and RasGEF1B 
were cloned into pGEX vector system which has GST-tag. That system indeed 
increased the expression and purification efficiencies of these proteins compared to 
His-tag system but still the amount of the proteins were much less than the amount of 
Ccdc-124 protein. On the other hand, when we tried to cleave the GST-tag, proteins 
were immediately precipitated. That is why, we purified RasGEF1 proteins with GST 
tag. In order to complete all the experiments we had to purify RasGEF1 proteins 
more than 5 times. On the other hand, since polarization assays take a lot of time and 
protein, we couldn‟t exactly completed the polarization assays because after some 
point RasGEF1B protein started to precipitate. But the increase in the polarization 
rates most probably indicate the binding of Ccdc-124 and RasGEF1B proteins.  
Previous studies focusing on the cellular functions of Rap proteins have revealed that 
they could function independently of Ras. Rap1 has been studied extensively in 
many different cell types and organisms, and it has critical roles in cytoskeletal 
rearrangement, integrin-mediated cell adhesion, platelet activation, and cadherin-
mediated cell junction formation (Bos 2006; Bos et al. 2001). Even though the 
expression patterns of Rap1 and Rap2 overlap, much less is known about a particular 
function of Rap2, indicating that the two subgroups (Rap1 and Rap2) could have 
different functions and be differentially regulated (Fu et al. 2007; Schmidt et al. 
2001; Zhu et al. 2005). Supporting the notion of different functions, it has been 
shown that Rap2 is not involved in integrin activation but rather in Wnt–b-catenin 
signaling during dorsoventral patterning in Xenopus development (Choi and Han 
2005), and that Rap2, but not Rap1, is expressed in red blood cells (Greco et al. 
2006). We screened a large set of small GTP-binding proteins of the Ras subfamily 
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for stimulation of nucleotide exchange by two previously uncharacterized putative 
GEFs of the Cdc25 family, RasGEF1A and RasGEF1B. Both factors stimulated 
nucleotide exchange of only Rap2A, and did not have any effect at all on other 
distantly or closely related members of the Ras family. Comparison of exchange 
reaction rates of RasGEF1A and RasGEF1B suggested that RasGEF1A leads to 
about 20-fold faster release of nucleotide from Rap2A than that seen in the presence 
of RasGEF1B (Table 3.1). We noticed that the nucleotide exchange rate of 
RasGEF1B is also slower than that of other RapGEFs, such as Epac or C3G (Gasper 
et al. 2008). RasGEF1A and RasGEF1B are comparatively small GEFs, without any 
apparent additional domain that could potentially be autoinhibitory. However, weak 
affinities between GEFs and their cognate G-proteins have been noticed previously, 
and could indicate that, in vivo, RasGEF1 activity is substantially increased by 
translocation to the plasma or internal membranes, which increases the local 
concentration of substrate and enzyme. A multiple human tissue northern blot 
analysis carried out by Ura et al. (Ura et al. 2006) revealed that brain and spinal cord 
are two tissues with very strong RasGEF1A expression. In contrast to our data, these 
authors reported that RasGEF1A could act as a GEF for H-Ras, K-Ras, and N-Ras. 
In our opinion, this might be an artifactual result, as in their work both G proteins 
and GEFs were containing GST-tags, and dimerization of GSTs might have led to 
artifactual close interactions between GEFs and G proteins. In our hands, when 
unfused Ras proteins were used rather than GST-linked proteins, and 
phosphocellulose filter binding was avoided, RasGEF1A has no effect on the 
nucleotide exchange of classic Ras proteins in the solution assay.  
The gene encoding murine RasGEF1B was first identified in a study reporting 
upregulation of its expression in macrophages in response to mucin-like 
glycoproteins of a protozoan parasite, Trypanosoma cruzi, and it was initially named 
GPIc4 (Ferreira et al. 2002). A study on tissue-specific expression of RasGEF1B 
homolog in developing zebrafish embryos indicated that this gene is also strongly 
expressed in midbrain and hindbrain tissues (Epting et al. 2007). Interestingly, 
specific functions of Rap2 were identified in different neuronal processes, such as 
synaptic depotentiation and modulation of neuronal morphology (Fu et al. 2007; 
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Schmidt et al. 2001; Spilker et al. 2008; Zhu et al. 2005), and it is possible that the 
two RasGEF1 family members play critical roles in the spatial and temporal 
regulation of Rap2 activity at different rates in hippocampal neurons during the 
control of excitatory synapses.  
Although the structural model of the RasGEF1– Rap2 complex suggested Ser66 in 
the switch II region to be located in or close to the interface, the S66A mutation in 
Rap2A did not affect nucleotide exchange by RasGEF1 family members, suggesting 
that the mild Ser to Ala substitution can easily be accommodated in the interface. 
This is in line with the structure of the Epac–Rap1 complex, where Ala66 makes a 
main chain water-mediated contact with Asn803 of Epac (Rehmann et al. 2008). 
Whereas wild-type Rap2 is not stimulated by C3G, the double-mutated (T65A ⁄ 
S66A) Rap2 can be partially stimulated by C3G, just as a more extensive quadruple 
mutation of the switch II region made Ras partially responsive to C3G (van den 
Berghe et al. 1999). All of this supports the notion that the switch II region is 
involved in binding and specificity, and that the interface between Cdc25-GEFs and 
their cognate G-proteins shows great plasticity (Boriack-Sjodin et al. 1998; Rehmann 
et al. 2008). Conversion of Thr27 in switch I of Rap2A to Ile (as in Rap1) reduces 
the nucleotide exchange rate (Fig.3.68), indicating a functional role for this residue. 
The most dramatic effect is, however, due to the F39S mutation in Rap2A, which 
completely abolished nucleotide exchange activity by the two cognate GEFs, 
RasGEF1A and RasGEF1B (Fig.3.68). Residue 39 is located in the switch I region 
previously shown to be critical in Ras–Cdc25, Rap–Epac and Rap1–C3G interactions 
(Boriack-Sjodin et al. 1998; Rehmann et al. 2008; van den Berghe et al. 1999). 
Furthermore, it was previously shown that mutations at Thr35 and Glu37 positioned 
in the switch I region of Rap1 decreased its interaction with C3G by a factor of four 
(van den Berghe et al. 1999). These previous data are in agreement with our results 
regarding the critical role of the switch I region and, in particular, Phe39 in the 
interaction of Rap2A with RasGEF1A and Ras- GEF1B. Phe39 is also a specificity 
determinant, as the S39F mutation in Rap1B allows RasGEF1B to act on Rap1B. As 
RasGEF1A does not have the same stimulatory effect on Rap1(S39F), regardless of 
its concentration (from 200 nm up to 20 µm; Fig.3.72), this suggests that the two 
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GEFs establish different contacts even though they are 61% identical. These results 
indicate that even a single amino acid difference in the switch I region of Rap GTP-
binding proteins may determine the specificities of interactions with cognate 
nucleotide exchange factors. In fact, in a previous study, residue 39 was also shown 
to determine the specificity of interaction of Rap2 with the downstream effector 
RAPL⁄NORE (Miertzschke et al. 2007). The Phe39 to Ser39 sequence difference in 
the switch I region of Rap1 and Rap2 is thus a major determinant of the activation of 
different Rap group members and their downstream biological effects. 
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5 FUTURE PERSPECTIVES 
In this thesis, we have first identified the interaction of Ccdc-124 and RasGEF1 
family of proteins. Then, we have shown that RasGEF1 family members, RasGEF1A 
and RasGEF1B stimulate guanine nucleotide exchange of Rap2, but not of Rap1, in 
in vitro assay conditions. Under same conditions, Ccdc-124 neither stimulates, nor 
inhibits RasGEF1 functions, even though the two proteins interact with each other. 
Immediate future studies will include assessments of Rap2 regulatory functions of 
RasGEF1s and the effect of Ccdc-124 on this regulation (if any) in vivo. For this 
purpose RasGEF1 family members and Ccdc-124 can be knocked-down by specific 
shRNA molecules, and the biological read-outs can be monitored. In fact, 
interestingly, both canonical and non-canonical Wnt pathways were shown to be 
under control of Rap2 proteins, and not of Rap1 (Choi et al., 2005). Therefore, as 
one of the pathways that could be modulated by such knock-downs could be the Wnt 
pathway, we are planning to analyze Wnt pathway activities and the stability of β-
catenin in RasGEF1/Ccdc-124 down-regulated cellular conditions.  
Subcellular localizations of RasGEF1 family members and Ccdc-124 were not fully 
established. Even though we have observed a cytoplasmic localization pattern for 
Ccdc-124, we have not correlated it with the localizations of well established Golgi, 
ER, or vesicle specific markers. There are a number of molecular ways to modulate 
activities of GEFs such as 1) binding of small molecules (cAMP, DAG, Ca
++
), 2) 
protein-protein interactions leading to stimulation/inhibition of GEFs, 3) acting as 
binding partners that bring them close to regulatory proteins, 4) or changing their 
subcellular localizations in order to bring them to proximities of their substrates. It is 
plausible to think that Ccdc-124 could stimulate RasGEF1 family members by 
changing their localizations, and if this is the case, then it would have been 
impossible to detect its stimulatory effect by our assay system. Ccdc-124 could 
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maintain this activity after going through post-translational modifications that have 
not been thoroughly analyzed yet. In fact, in bioinformatics data bases, Ccdc-124 is 
predicted to be a phospho-protein. Future work should adress if Ccdc-124 is 
modified in vivo, and how these in vivo modifications might affect the biological 
functions of the protein. 
Ccdc-124 is a relatively small gene composed of 4  exons, and the region it covers is 
around 3 kb in total. Therefore, in theory deleting the gene in mice genome would be 
relatively easy, and detection of knock-outs will be less complicated as compared to 
genes of superior complexity. We have already obtained mouse Bac clones having 
the region with the locus encoding Ccdc-124 as well as all vector systems to create 
Cre-Lox constructs in our laboratory. Following resuts obtained from shRNA 
experiments where Ccdc-124 will be knocked-down in cells, and its biological effect 
on signaling pathways (Wnt/β-catenin) will be assessed, we are also planning to 
make Ccdc-124 knock-out mice. These mice might let us establish unequivocally the 
biological function of this novel conserved gene. 
 
 
  
100 
6  REFERENCES 
1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller 
and D. J. Lipman (1997). "Gapped BLAST and PSI-BLAST: a new 
generation of protein database search programs." Nucleic Acids Res 25(17): 
3389-3402. 
2. Arthur, W. T., L. A. Quilliam and J. A. Cooper (2004). "Rap1 promotes cell 
spreading by localizing Rac guanine nucleotide exchange factors." J Cell Biol 
167(1): 111-122. 
3. Beranger, F., B. Goud, A. Tavitian and J. de Gunzburg (1991). "Association 
of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex." Proc 
Natl Acad Sci U S A 88(5): 1606-1610. 
4. Beranger, F., A. Tavitian and J. de Gunzburg (1991). "Post-translational 
processing and subcellular localization of the Ras-related Rap2 protein." 
Oncogene 6(10): 1835-1842. 
5. Boriack-Sjodin, P. A., S. M. Margarit, D. Bar-Sagi and J. Kuriyan (1998). 
"The structural basis of the activation of Ras by Sos." Nature 394(6691): 337-
343. 
6. Bos, J. L. (2006). "Epac proteins: multi-purpose cAMP targets." Trends 
Biochem Sci 31(12): 680-686. 
7. Bos, J. L., K. de Bruyn, J. Enserink, B. Kuiperij, S. Rangarajan, H. Rehmann, 
J. Riedl, J. de Rooij, F. van Mansfeld and F. Zwartkruis (2003). "The role of 
Rap1 in integrin-mediated cell adhesion." Biochem Soc Trans 31(Pt 1): 83-
86. 
8. Bos, J. L., J. de Rooij and K. A. Reedquist (2001). "Rap1 signalling: adhering 
to new models." Nat Rev Mol Cell Biol 2(5): 369-377. 
9. Bos, J. L., H. Rehmann and A. Wittinghofer (2007). "GEFs and GAPs: 
critical elements in the control of small G proteins." Cell 129(5): 865-877. 
10. Choi, S. C. and J. K. Han (2005). "Rap2 is required for Wnt/beta-catenin 
signaling pathway in Xenopus early development." EMBO J 24(5): 985-996. 
11. Choi, S. C., G. H. Kim, S. J. Lee, E. Park, C. Y. Yeo and J. K. Han (2008). 
"Regulation of activin/nodal signaling by Rap2-directed receptor trafficking." 
Dev Cell 15(1): 49-61. 
12. Christian, S. L., R. L. Lee, S. J. McLeod, A. E. Burgess, A. H. Li, M. Dang-
Lawson, K. B. Lin and M. R. Gold (2003). "Activation of the Rap GTPases in 
B lymphocytes modulates B cell antigen receptor-induced activation of Akt 
but has no effect on MAPK activation." J Biol Chem 278(43): 41756-41767. 
13. Colicelli, J. (2004). "Human RAS superfamily proteins and related GTPases." 
Sci STKE 2004(250): RE13. 
14. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. 
Wittinghofer and J. L. Bos (1998). "Epac is a Rap1 guanine-nucleotide-
  
101 
exchange factor directly activated by cyclic AMP." Nature 396(6710): 474-
477. 
15. Ehrhardt, A., G. R. Ehrhardt, X. Guo and J. W. Schrader (2002). "Ras and 
relatives--job sharing and networking keep an old family together." Exp 
Hematol 30(10): 1089-1106. 
16. Emsley, P. and K. Cowtan (2004). "Coot: model-building tools for molecular 
graphics." Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1): 2126-2132. 
17. Enserink, J. M., L. S. Price, T. Methi, M. Mahic, A. Sonnenberg, J. L. Bos 
and K. Tasken (2004). "The cAMP-Epac-Rap1 pathway regulates cell 
spreading and cell adhesion to laminin-5 through the alpha3beta1 integrin but 
not the alpha6beta4 integrin." J Biol Chem 279(43): 44889-44896. 
18. Epting, D., S. Vorwerk, A. Hageman and D. Meyer (2007). "Expression of 
rasgef1b in zebrafish." Gene Expr Patterns 7(4): 389-395. 
19. Esters, H., K. Alexandrov, A. Iakovenko, T. Ivanova, N. Thoma, V. Rybin, 
M. Zerial, A. J. Scheidig and R. S. Goody (2001). "Vps9, Rabex-5 and DSS4: 
proteins with weak but distinct nucleotide-exchange activities for Rab 
proteins." J Mol Biol 310(1): 141-156. 
20. Ferreira, L. R., E. F. Abrantes, C. V. Rodrigues, B. Caetano, G. C. Cerqueira, 
A. C. Salim, L. F. Reis and R. T. Gazzinelli (2002). "Identification and 
characterization of a novel mouse gene encoding a Ras-associated guanine 
nucleotide exchange factor: expression in macrophages and myocarditis 
elicited by Trypanosoma cruzi parasites." J Leukoc Biol 72(6): 1215-1227. 
21. Formstecher, E., S. Aresta, V. Collura, A. Hamburger, A. Meil, A. Trehin, C. 
Reverdy, V. Betin, S. Maire, C. Brun, B. Jacq, M. Arpin, Y. Bellaiche, S. 
Bellusci, P. Benaroch, M. Bornens, R. Chanet, P. Chavrier, O. Delattre, V. 
Doye, R. Fehon, G. Faye, T. Galli, J. A. Girault, B. Goud, J. de Gunzburg, L. 
Johannes, M. P. Junier, V. Mirouse, A. Mukherjee, D. Papadopoulo, F. Perez, 
A. Plessis, C. Rosse, S. Saule, D. Stoppa-Lyonnet, A. Vincent, M. White, P. 
Legrain, J. Wojcik, J. Camonis and L. Daviet (2005). "Protein interaction 
mapping: a Drosophila case study." Genome Res 15(3): 376-384. 
22. Fromont-Racine, M., J. C. Rain and P. Legrain (1997). "Toward a functional 
analysis of the yeast genome through exhaustive two-hybrid screens." Nat 
Genet 16(3): 277-282. 
23. Fu, Z., S. H. Lee, A. Simonetta, J. Hansen, M. Sheng and D. T. Pak (2007). 
"Differential roles of Rap1 and Rap2 small GTPases in neurite retraction and 
synapse elimination in hippocampal spiny neurons." J Neurochem 100(1): 
118-131. 
24. Gao, X., T. Satoh, Y. Liao, C. Song, C. D. Hu, K. Kariya Ki and T. Kataoka 
(2001). "Identification and characterization of RA-GEF-2, a Rap guanine 
nucleotide exchange factor that serves as a downstream target of M-Ras." J 
Biol Chem 276(45): 42219-42225. 
25. Gasper, R., C. Thomas, M. R. Ahmadian and A. Wittinghofer (2008). "The 
role of the conserved switch II glutamate in guanine nucleotide exchange 
factor-mediated nucleotide exchange of GTP-binding proteins." J Mol Biol 
379(1): 51-63. 
26. Gotoh, T., S. Hattori, S. Nakamura, H. Kitayama, M. Noda, Y. Takai, K. 
Kaibuchi, H. Matsui, O. Hatase, H. Takahashi and et al. (1995). 
  
102 
"Identification of Rap1 as a target for the Crk SH3 domain-binding guanine 
nucleotide-releasing factor C3G." Mol Cell Biol 15(12): 6746-6753. 
27. Greco, F., A. Ciana, D. Pietra, C. Balduini, G. Minetti and M. Torti (2006). 
"Rap2, but not Rap1 GTPase is expressed in human red blood cells and is 
involved in vesiculation." Biochim Biophys Acta 1763(3): 330-335. 
28. Harrington, A. T., P. D. Hearn, W. L. Picking, J. R. Barker, A. Wessel and 
W. D. Picking (2003). "Structural characterization of the N terminus of IpaC 
from Shigella flexneri." Infect Immun 71(3): 1255-1264. 
29. Hogan, C., N. Serpente, P. Cogram, C. R. Hosking, C. U. Bialucha, S. M. 
Feller, V. M. Braga, W. Birchmeier and Y. Fujita (2004). "Rap1 regulates the 
formation of E-cadherin-based cell-cell contacts." Mol Cell Biol 24(15): 
6690-6700. 
30. Huang, C. C., J. L. You, M. Y. Wu and K. S. Hsu (2004). "Rap1-induced p38 
mitogen-activated protein kinase activation facilitates AMPA receptor 
trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-
dihydroxyphenylglycene-induced long term depression." J Biol Chem 
279(13): 12286-12292. 
31. Imamura, Y., N. Matsumoto, S. Kondo, H. Kitayama and M. Noda (2003). 
"Possible involvement of Rap1 and Ras in glutamatergic synaptic 
transmission." Neuroreport 14(9): 1203-1207. 
32. Jamora, C. and E. Fuchs (2002). "Intercellular adhesion, signalling and the 
cytoskeleton." Nat Cell Biol 4(4): E101-108. 
33. Janoueix-Lerosey, I., P. Polakis, A. Tavitian and J. de Gunzburg (1992). 
"Regulation of the GTPase activity of the ras-related rap2 protein." Biochem 
Biophys Res Commun 189(1): 455-464. 
34. Jimenez, B., V. Pizon, I. Lerosey, F. Beranger, A. Tavitian and J. de 
Gunzburg (1991). "Effects of the ras-related rap2 protein on cellular 
proliferation." Int J Cancer 49(3): 471-479. 
35. Jones, S., M. L. Vignais and J. R. Broach (1991). "The CDC25 protein of 
Saccharomyces cerevisiae promotes exchange of guanine nucleotides bound 
to ras." Mol Cell Biol 11(5): 2641-2646. 
36. Kardassis, D., C. Murphy, T. Fotsis, A. Moustakas and C. Stournaras (2009). 
"Control of transforming growth factor beta signal transduction by small 
GTPases." FEBS J 276(11): 2947-2965. 
37. Karnoub, A. E. and R. A. Weinberg (2008). "Ras oncogenes: split 
personalities." Nat Rev Mol Cell Biol 9(7): 517-531. 
38. Kawasaki, H., G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. 
Matsuda, D. E. Housman and A. M. Graybiel (1998). "A family of cAMP-
binding proteins that directly activate Rap1." Science 282(5397): 2275-2279. 
39. Kawasaki, H., G. M. Springett, S. Toki, J. J. Canales, P. Harlan, J. P. 
Blumenstiel, E. J. Chen, I. A. Bany, N. Mochizuki, A. Ashbacher, M. 
Matsuda, D. E. Housman and A. M. Graybiel (1998). "A Rap guanine 
nucleotide exchange factor enriched highly in the basal ganglia." Proc Natl 
Acad Sci U S A 95(22): 13278-13283. 
40. Kiger, A. A., B. Baum, S. Jones, M. R. Jones, A. Coulson, C. Echeverri and 
N. Perrimon (2003). "A functional genomic analysis of cell morphology 
using RNA interference." J Biol 2(4): 27. 
  
103 
41. Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa and M. Noda (1989). "A 
ras-related gene with transformation suppressor activity." Cell 56(1): 77-84. 
42. Klebe, C., H. Prinz, A. Wittinghofer and R. S. Goody (1995). "The kinetic 
mechanism of Ran--nucleotide exchange catalyzed by RCC1." Biochemistry 
34(39): 12543-12552. 
43. Knox, A. L. and N. H. Brown (2002). "Rap1 GTPase regulation of adherens 
junction positioning and cell adhesion." Science 295(5558): 1285-1288. 
44. Lenzen, C., R. H. Cool and A. Wittinghofer (1995). "Analysis of intrinsic and 
CDC25-stimulated guanine nucleotide exchange of p21ras-nucleotide 
complexes by fluorescence measurements." Methods Enzymol 255: 95-109. 
45. Liao, Y., K. Kariya, C. D. Hu, M. Shibatohge, M. Goshima, T. Okada, Y. 
Watari, X. Gao, T. G. Jin, Y. Yamawaki-Kataoka and T. Kataoka (1999). 
"RA-GEF, a novel Rap1A guanine nucleotide exchange factor containing a 
Ras/Rap1A-associating domain, is conserved between nematode and 
humans." J Biol Chem 274(53): 37815-37820. 
46. Liao, Y., T. Satoh, X. Gao, T. G. Jin, C. D. Hu and T. Kataoka (2001). "RA-
GEF-1, a guanine nucleotide exchange factor for Rap1, is activated by 
translocation induced by association with Rap1*GTP and enhances Rap1-
dependent B-Raf activation." J Biol Chem 276(30): 28478-28483. 
47. Marti-Renom, M. A., A. C. Stuart, A. Fiser, R. Sanchez, F. Melo and A. Sali 
(2000). "Comparative protein structure modeling of genes and genomes." 
Annu Rev Biophys Biomol Struct 29: 291-325. 
48. McLeod, S. J., A. H. Li, R. L. Lee, A. E. Burgess and M. R. Gold (2002). 
"The Rap GTPases regulate B cell migration toward the chemokine stromal 
cell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cell 
migration." J Immunol 169(3): 1365-1371. 
49. McLeod, S. J., A. J. Shum, R. L. Lee, F. Takei and M. R. Gold (2004). "The 
Rap GTPases regulate integrin-mediated adhesion, cell spreading, actin 
polymerization, and Pyk2 tyrosine phosphorylation in B lymphocytes." J Biol 
Chem 279(13): 12009-12019. 
50. Miertzschke, M., P. Stanley, T. D. Bunney, F. Rodrigues-Lima, N. Hogg and 
M. Katan (2007). "Characterization of interactions of adapter protein 
RAPL/Nore1B with RAP GTPases and their role in T cell migration." J Biol 
Chem 282(42): 30629-30642. 
51. Mistou, M. Y., E. Jacquet, P. Poullet, H. Rensland, P. Gideon, I. Schlichting, 
A. Wittinghofer and A. Parmeggiani (1992). "Mutations of Ha-ras p21 that 
define important regions for the molecular mechanism of the SDC25 C-
domain, a guanine nucleotide dissociation stimulator." EMBO J 11(7): 2391-
2397. 
52. Mosteller, R. D., W. Park and D. Broek (1995). "Analysis of interaction 
between Ras and CDC25 guanine nucleotide exchange factor using yeast 
GAL4 two-hybrid system." Methods Enzymol 255: 135-148. 
53. Nancy, V., R. M. Wolthuis, M. F. de Tand, I. Janoueix-Lerosey, J. L. Bos and 
J. de Gunzburg (1999). "Identification and characterization of potential 
effector molecules of the Ras-related GTPase Rap2." J Biol Chem 274(13): 
8737-8745. 
  
104 
54. Ohba, Y., N. Mochizuki, K. Matsuo, S. Yamashita, M. Nakaya, Y. 
Hashimoto, M. Hamaguchi, T. Kurata, K. Nagashima and M. Matsuda 
(2000). "Rap2 as a slowly responding molecular switch in the Rap1 signaling 
cascade." Mol Cell Biol 20(16): 6074-6083. 
55. Paganini, S., G. F. Guidetti, S. Catricala, P. Trionfini, S. Panelli, C. Balduini 
and M. Torti (2006). "Identification and biochemical characterization of 
Rap2C, a new member of the Rap family of small GTP-binding proteins." 
Biochimie 88(3-4): 285-295. 
56. Pellis-van Berkel, W., M. H. Verheijen, E. Cuppen, M. Asahina, J. de Rooij, 
G. Jansen, R. H. Plasterk, J. L. Bos and F. J. Zwartkruis (2005). 
"Requirement of the Caenorhabditis elegans RapGEF pxf-1 and rap-1 for 
epithelial integrity." Mol Biol Cell 16(1): 106-116. 
57. Price, L. S. and J. L. Bos (2004). "RAPL: taking the Rap in immunity." Nat 
Immunol 5(10): 1007-1008. 
58. Price, L. S., A. Hajdo-Milasinovic, J. Zhao, F. J. Zwartkruis, J. G. Collard 
and J. L. Bos (2004). "Rap1 regulates E-cadherin-mediated cell-cell 
adhesion." J Biol Chem 279(34): 35127-35132. 
59. Quilliam, L. A., M. M. Hisaka, S. Zhong, A. Lowry, R. D. Mosteller, J. Han, 
J. K. Drugan, D. Broek, S. L. Campbell and C. J. Der (1996). "Involvement 
of the switch 2 domain of Ras in its interaction with guanine nucleotide 
exchange factors." J Biol Chem 271(19): 11076-11082. 
60. Quilliam, L. A., J. F. Rebhun and A. F. Castro (2002). "A growing family of 
guanine nucleotide exchange factors is responsible for activation of Ras-
family GTPases." Prog Nucleic Acid Res Mol Biol 71: 391-444. 
61. Rain, J. C., L. Selig, H. De Reuse, V. Battaglia, C. Reverdy, S. Simon, G. 
Lenzen, F. Petel, J. Wojcik, V. Schachter, Y. Chemama, A. Labigne and P. 
Legrain (2001). "The protein-protein interaction map of Helicobacter pylori." 
Nature 409(6817): 211-215. 
62. Reedquist, K. A., E. Ross, E. A. Koop, R. M. Wolthuis, F. J. Zwartkruis, Y. 
van Kooyk, M. Salmon, C. D. Buckley and J. L. Bos (2000). "The small 
GTPase, Rap1, mediates CD31-induced integrin adhesion." J Cell Biol 
148(6): 1151-1158. 
63. Rehmann, H. (2006). "Characterization of the activation of the Rap-specific 
exchange factor Epac by cyclic nucleotides." Methods Enzymol 407: 159-
173. 
64. Rehmann, H., E. Arias-Palomo, M. A. Hadders, F. Schwede, O. Llorca and J. 
L. Bos (2008). "Structure of Epac2 in complex with a cyclic AMP analogue 
and RAP1B." Nature 455(7209): 124-127. 
65. Remmers, A. E., R. Posner and R. R. Neubig (1994). "Fluorescent guanine 
nucleotide analogs and G protein activation." J Biol Chem 269(19): 13771-
13778. 
66. Rual, J. F., J. Ceron, J. Koreth, T. Hao, A. S. Nicot, T. Hirozane-Kishikawa, 
J. Vandenhaute, S. H. Orkin, D. E. Hill, S. van den Heuvel and M. Vidal 
(2004). "Toward improving Caenorhabditis elegans phenome mapping with 
an ORFeome-based RNAi library." Genome Res 14(10B): 2162-2168. 
67. Schmidt, M., S. Evellin, P. A. Weernink, F. von Dorp, H. Rehmann, J. W. 
Lomasney and K. H. Jakobs (2001). "A new phospholipase-C-calcium 
  
105 
signalling pathway mediated by cyclic AMP and a Rap GTPase." Nat Cell 
Biol 3(11): 1020-1024. 
68. Spilker, C., G. A. Acuna Sanhueza, T. M. Bockers, M. R. Kreutz and E. D. 
Gundelfinger (2008). "SPAR2, a novel SPAR-related protein with GAP 
activity for Rap1 and Rap2." J Neurochem 104(1): 187-201. 
69. Takai, Y., T. Sasaki and T. Matozaki (2001). "Small GTP-binding proteins." 
Physiol Rev 81(1): 153-208. 
70. Ura, K., K. Obama, S. Satoh, Y. Sakai, Y. Nakamura and Y. Furukawa 
(2006). "Enhanced RASGEF1A expression is involved in the growth and 
migration of intrahepatic cholangiocarcinoma." Clin Cancer Res 12(22): 
6611-6616. 
71. van den Berghe, N., R. H. Cool, G. Horn and A. Wittinghofer (1997). 
"Biochemical characterization of C3G: an exchange factor that discriminates 
between Rap1 and Rap2 and is not inhibited by Rap1A(S17N)." Oncogene 
15(7): 845-850. 
72. van den Berghe, N., R. H. Cool and A. Wittinghofer (1999). "Discriminatory 
residues in Ras and Rap for guanine nucleotide exchange factor recognition." 
J Biol Chem 274(16): 11078-11085. 
73. Vetter, I. R. and A. Wittinghofer (2001). "The guanine nucleotide-binding 
switch in three dimensions." Science 294(5545): 1299-1304. 
74. Weirich, C. S., J. P. Erzberger and Y. Barral (2008). "The septin family of 
GTPases: architecture and dynamics." Nat Rev Mol Cell Biol 9(6): 478-489. 
75. Wennerberg, K., K. L. Rossman and C. J. Der (2005). "The Ras superfamily 
at a glance." J Cell Sci 118(Pt 5): 843-846. 
76. Wojcik, J., I. G. Boneca and P. Legrain (2002). "Prediction, assessment and 
validation of protein interaction maps in bacteria." J Mol Biol 323(4): 763-
770. 
77. Yajnik, V., C. Paulding, R. Sordella, A. I. McClatchey, M. Saito, D. C. 
Wahrer, P. Reynolds, D. W. Bell, R. Lake, S. van den Heuvel, J. Settleman 
and D. A. Haber (2003). "DOCK4, a GTPase activator, is disrupted during 
tumorigenesis." Cell 112(5): 673-684. 
78. Zhu, Y., D. Pak, Y. Qin, S. G. McCormack, M. J. Kim, J. P. Baumgart, V. 
Velamoor, Y. P. Auberson, P. Osten, L. van Aelst, M. Sheng and J. J. Zhu 
(2005). "Rap2-JNK removes synaptic AMPA receptors during 
depotentiation." Neuron 46(6): 905-916. 
 
 
 
 
